TAK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NKT7 | T1210 | Sugiyama | RGPD3 RGP3 | KLIQRAEEMKSGLKDFKTFLtNDQTKVAEEENKGSGTGAAG |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00571 | S71 | Sugiyama | DDX3X DBX DDX3 | GFyDKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGsG |
| O14715 | T1209 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | KLIQRAEEMKSGLKDFKTFLtNDQTKVTEEENKGsGTGVAG |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14920 | S177 | SIGNOR|EPSD|PSP | IKBKB IKKB | EQRLIHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQ |
| O14920 | S181 | SIGNOR|EPSD|PSP | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O15067 | S227 | Sugiyama | PFAS KIAA0361 | FQELQRNPstVEAFDLAQsNsEHSRHWFFKGQLHVDGQKLV |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O15523 | S71 | Sugiyama | DDX3Y DBY | GFHDKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSGS |
| O43318 | S192 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAP3K7 TAK1 | KICDFGtACDIQtHMtNNKGsAAWMAPEVFEGSNySEKCDV |
| O43318 | T178 | SIGNOR|EPSD|PSP | MAP3K7 TAK1 | KPPNLLLVAGGTVLKICDFGtACDIQtHMtNNKGsAAWMAP |
| O43318 | T184 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MAP3K7 TAK1 | LVAGGTVLKICDFGtACDIQtHMtNNKGsAAWMAPEVFEGS |
| O43318 | T187 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAP3K7 TAK1 | GGTVLKICDFGtACDIQtHMtNNKGsAAWMAPEVFEGSNyS |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43423 | T101 | Sugiyama | ANP32CP PP32R1 | EKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCEV |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y906 | Sugiyama | ACTN4 | yQGPDAVPGALDyKsFStALyGEsDL_______________ |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75369 | S905 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | NsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTYG |
| O75369 | T907 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTYGGD |
| O75369 | Y902 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VQFNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLV |
| O75506 | T29 | Sugiyama | HSBP1 HSF1BP | VQDLTSVVQTLLQQMQDKFQtMsDQIIGRIDDMSSRIDDLE |
| O94776 | Y437 | Sugiyama | MTA2 MTA1L1 PID | tTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQ |
| O94992 | Y274 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | GMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELIKEyLEL |
| O95626 | T105 | Sugiyama | ANP32D PP32R2 | EKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCEV |
| O95757 | T365 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | TRIPAVKEQITKFFLKDISTtLNADEAVARGCALQCAILsP |
| P00338 | T3 | EPSD|PSP | LDHA PIG19 | __________________MAtLKDQLIyNLLKEEQtPQNKI |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00390 | T365 | Sugiyama | GSR GLUR GRD1 | NKLGIQTDDKGHIIVDEFQNtNVKGIyAVGDVCGKALLtPV |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P04040 | T28 | Sugiyama | CAT | ASDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRG |
| P04040 | T29 | Sugiyama | CAT | SDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRGP |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | Y364 | Sugiyama | ALDOA ALDA | tPsGQAGAAAsEsLFVsNHAy____________________ |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04083 | T24 | Sugiyama | ANXA1 ANX1 LPC1 | VsEFLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPtFNP |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05787 | Y286 | Sugiyama | KRT8 CYK8 | QyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTE |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07205 | Y196 | Sugiyama | PGK2 PGKB | MVGVNLPHKASGFLMKKELDyFAKALENPVRPFLAILGGAK |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T166 | EPSD|PSP | TUBB TUBB5 OK/SW-cl.56 | GMGTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNAT |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07858 | T218 | Sugiyama | CTSB CPSB | CTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSEKD |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P08195 | T321 | Sugiyama | SLC3A2 MDU1 | SIRVILDLTPNYRGENSWFStQVDtVATKVKDALEFWLQAG |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T459 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEt |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P09234 | T11 | Sugiyama | SNRPC | __________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHK |
| P09234 | T14 | Sugiyama | SNRPC | _______MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENV |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0DJD0 | T1194 | Sugiyama | RGPD1 RANBP2L6 RGP1 | KLIQRAEEMKSGLKDFKTFLtNDQTKVTEEENKGsGtGAAG |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10809 | T113 | Sugiyama | HSPD1 HSP60 | IGAKLVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISK |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T427 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGER |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12814 | Y422 | Sugiyama | ACTN1 | KAsIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEs |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | T34 | Sugiyama | EEF2 EF2 | DKKANIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEt |
| P13639 | T36 | Sugiyama | EEF2 EF2 | KANIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRF |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13987 | T85 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | WKFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGT |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S674 | EPSD|PSP | HSP90B1 GRP94 HSPC4 TRA1 | WsGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLI |
| P14625 | T669 | EPSD|PSP | HSP90B1 GRP94 HSPC4 TRA1 | AsQyGWsGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINP |
| P14625 | T675 | EPSD|PSP | HSP90B1 GRP94 HSPC4 TRA1 | sGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIR |
| P15153 | T161 | Sugiyama | RAC2 | QGLALAKEIDSVKyLECsALtQRGLKtVFDEAIRAVLCPQP |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17812 | Y468 | Sugiyama | CTPS1 CTPS | MRLGKRRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVW |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P21333 | T1286 | EPSD|PSP | FLNA FLN FLN1 | EGQGVFREATTEFSVDARALtQtGGPHVKARVANPsGNLTE |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | T1016 | Sugiyama | UBA1 A1S9T UBE1 | MLYSFFMPAAKLKERLDQPMtEIVsRVSKRKLGRHVRALVL |
| P22314 | T233 | Sugiyama | UBA1 A1S9T UBE1 | GEQPLSAMVSMVTKDNPGVVtCLDEARHGFESGDFVSFSEV |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | T176 | EPSD|PSP | HNRNPA2B1 HNRPA2B1 | GFVtFDDHDPVDKIVLQKyHtINGHNAEVRKALsRQEMQEV |
| P23284 | T108 | Sugiyama | PPIB CYPB | YKNSKFHRVIKDFMIQGGDFtRGDGtGGKsIyGERFPDENF |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23588 | S230 | EPSD|PSP | EIF4B | DyPPRRGDDsFGDKYRDRYDsDRYRDGYRDGYRDGPRRDMD |
| P23921 | T555 | Sugiyama | RRM1 RR1 | IyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTP |
| P23921 | Y553 | Sugiyama | RRM1 RR1 | EtIyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNV |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26045 | S359 | SIGNOR|EPSD|PSP | PTPN3 PTPH1 | QYCKKVIGGMVWNPAMRRsLsVEHLEtKsLPsRsPPItPNW |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P27348 | T30 | Sugiyama | YWHAQ | AKLAEQAERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKN |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P28066 | T14 | Sugiyama | PSMA5 | _______MFLTRsEyDRGVNtFsPEGRLFQVEyAIEAIKLG |
| P29322 | Y651 | Sugiyama | EPHA8 EEK HEK3 KIAA1459 | EASRIHIEKIIGsGDSGEVCyGRLRVPGQRDVPVAIKALKA |
| P29322 | Y750 | Sugiyama | EPHA8 EEK HEK3 KIAA1459 | GQFTIMQLVGMLRGVGAGMRyLsDLGyVHRDLAARNVLVDS |
| P29322 | Y756 | Sugiyama | EPHA8 EEK HEK3 KIAA1459 | QLVGMLRGVGAGMRyLsDLGyVHRDLAARNVLVDSNLVCKV |
| P29322 | Y793 | Sugiyama | EPHA8 EEK HEK3 KIAA1459 | VCKVSDFGLsRVLEDDPDAAyTTtGGKIPIRWTAPEAIAFR |
| P29401 | T454 | Sugiyama | TKT | LAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICFIRTsR |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30307 | S216 | PSP | CDC25C | EFsLKDQEAKVSRsGLYRsPsMPENLNRPRLKQVEKFKDNt |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30533 | T248 | Sugiyama | LRPAP1 A2MRAP | LRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSAN |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | T326 | Sugiyama | CPS1 | AKTYKMSMANRGQNQPVLNItNKQAFITAQNHGYALDNTLP |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | S39 | Sugiyama | YWHAB | ERyDDMAAAMKAVtEQGHELsNEERNLLsVAyKNVVGARRS |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33121 | T695 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | KAKRPELRNYFRSQIDDLyStIKV_________________ |
| P33176 | T182 | Sugiyama | KIF5B KNS KNS1 | VPYVKGCTERFVCsPDEVMDtIDEGKSNRHVAVTNMNEHSS |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | S31 | Sugiyama | HSPA4 APG2 HSPH2 | QSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAA |
| P34932 | T364 | Sugiyama | HSPA4 APG2 HSPH2 | ATRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAILs |
| P35080 | T85 | Sugiyama | PFN2 | tLGAKKCSVIRDSLyVDGDCtMDIRTKsQGGEPTyNVAVGR |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38159 | T216 | EPSD|PSP | RBMX HNRPG RBMXP1 | REPLPSRRDVYLsPRDDGystKDsyssRDYPSSRDTRDYAP |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39019 | T36 | Sugiyama | RPS19 | RALAAFLKKSGKLKVPEWVDtVKLAKHKELAPyDENWFytR |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39687 | T105 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | EKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCEV |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | T1919 | Sugiyama | MKI67 | SAGKAMHTPKAAVGEEKDINtFVGtPVEKLDLLGNLPGsKR |
| P46459 | T19 | Sugiyama | NSF | __MAGRSMQAARCPTDELsLtNCAVVNEKDFQsGQHVIVRT |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P47756 | T202 | Sugiyama | CAPZB | SGsGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMEN |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49005 | T33 | EPSD|PSP | POLD2 | LLsPPSANNATFARVPVATYtNSSQPFRLGERSFSRQYAHI |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y277 | Sugiyama | FASN FAS | KEQGVtFPsGDIQEQLIRSLyQsAGVAPEsFEyIEAHGtGT |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49736 | Y234 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | VFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLPEAPAE |
| P49792 | T2185 | Sugiyama | RANBP2 NUP358 | KLIQRAEEMKSGLKDFKTFLtNDQTKVTEEENKGsGtGAAG |
| P50395 | T205 | Sugiyama | GDI2 RABGDIB | TGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsPYL |
| P50990 | T398 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | RGstDNLMDDIERAVDDGVNtFKVLTRDKRLVPGGGAtEIE |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P50991 | T71 | Sugiyama | CCT4 CCTD SRB | sLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAARML |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P52564 | S207 | EPSD | MAP2K6 MEK6 MKK6 PRKMK6 SKK3 | INALGQVKMCDFGISGyLVDsVAKtIDAGCKPyMAPERINP |
| P52564 | T211 | EPSD | MAP2K6 MEK6 MKK6 PRKMK6 SKK3 | GQVKMCDFGISGyLVDsVAKtIDAGCKPyMAPERINPELNQ |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P54577 | Y289 | Sugiyama | YARS1 YARS | FPLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDL |
| P54577 | Y292 | Sugiyama | YARS1 YARS | KSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLKNS |
| P54646 | T172 | EPSD|PSP | PRKAA2 AMPK AMPK2 | NAKIADFGLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55010 | T227 | Sugiyama | EIF5 | ttEEAQRRRMDEISDHAKVLtLsDDLERtIEERVNILFDFV |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P56524 | S246 | EPSD|PSP | HDAC4 KIAA0288 | NHPVLGMYDAKDDFPLRKTAsEPNLKLRSRLKQKVAERRss |
| P60174 | S106 | Sugiyama | TPI1 TPI | DCGAtWVVLGHsERRHVFGEsDELIGQKVAHALAEGLGVIA |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T28 | Sugiyama | TPI1 TPI | FVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVVCAPPtAy |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60228 | T439 | Sugiyama | EIF3E EIF3S6 INT6 | AMNIEKKLNQNSRSEAPNWAtQDsGFy______________ |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60763 | T161 | Sugiyama | RAC3 | QGLAMAREIGSVKyLECsALtQRGLKtVFDEAIRAVLCPPP |
| P61006 | T72 | SIGNOR|PSP | RAB8A MEL RAB8 | LDGKRIKLQIWDtAGQERFRtITTAYYRGAMGIMLVYDITN |
| P61158 | S232 | Sugiyama | ACTR3 ARP3 | EVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKW |
| P61158 | Y231 | Sugiyama | ACTR3 ARP3 | REVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSK |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62820 | T75 | SIGNOR|EPSD|PSP | RAB1A RAB1 | LDGKTIKLQIWDtAGQERFRtItsSYYRGAHGIIVVYDVTD |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63000 | T161 | Sugiyama | RAC1 TC25 MIG5 | QGLAMAKEIGAVKyLECsALtQRGLKtVFDEAIRAVLCPPP |
| P63104 | S37 | Sugiyama | YWHAZ | ERyDDMAACMKsVtEQGAELsNEERNLLsVAyKNVVGARRs |
| P63104 | T232 | Sugiyama | YWHAZ | KDstLIMQLLRDNLtLWtsDtQGDEAEAGEGGEN_______ |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67936 | T241 | Sugiyama | TPM4 | EEKLAQAKEENVGLHQtLDQtLNELNCI_____________ |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | T261 | EPSD|PSP | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | T334 | EPSD|PSP|Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P78371 | T64 | Sugiyama | CCT2 99D8.1 CCTB | GPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVL |
| P78527 | T2647 | Sugiyama | PRKDC HYRC HYRC1 | ARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPL |
| P78527 | T2649 | Sugiyama | PRKDC HYRC HYRC1 | WPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPLVD |
| P84022 | S422 | iPTMNet|EPSD | SMAD3 MADH3 | GPLQWLDKVLTQMGsPsIRCssVs_________________ |
| P84022 | S423 | iPTMNet|EPSD | SMAD3 MADH3 | PLQWLDKVLTQMGsPsIRCssVs__________________ |
| P84022 | S425 | iPTMNet|EPSD | SMAD3 MADH3 | QWLDKVLTQMGsPsIRCssVs____________________ |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00839 | T582 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | CLGKFIEIAARKKRNFILDQtNVsAAAQRRKMCLFAGFQRK |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01094 | S337 | EPSD|PSP | E2F1 RBBP3 | TSEEENRAtDsAtIVsPPPssPPssLttDPSQSLLSLEQEP |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01130 | S212 | Sugiyama | SRSF2 SFRS2 | PPPVsKRESKSRSRsKsPPKsPEEEGAVss___________ |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01518 | Y164 | Sugiyama | CAP1 CAP | VAMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVK |
| Q02543 | Y97 | Sugiyama | RPL18A | NFGIWLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARH |
| Q02818 | S193 | Sugiyama | NUCB1 NUC | HEEFKRyEMLKEHERRRyLEsLGEEQRKEAERKLEEQQRRH |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q12906 | T300 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | ASGIVMPDGSGIYDPCEKEAtDAIGHLDRQQREDItQsAQH |
| Q13136 | T572 | Sugiyama | PPFIA1 LIP1 | LRRPQKGRLAALRDEPSKVQtLNEQDWERAQQASVLANVAQ |
| Q13200 | T351 | Sugiyama | PSMD2 TRAP2 | LALARELDIMEPKVPDDIyKtHLENNRFGGsGsQVDSARMN |
| Q13200 | Y349 | Sugiyama | PSMD2 TRAP2 | NFLALARELDIMEPKVPDDIyKtHLENNRFGGsGsQVDSAR |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14247 | T68 | Sugiyama | CTTN EMS1 | GHQEHINIHKLRENVFQEHQtLKEKELETGPKASHGyGGKF |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14697 | T229 | Sugiyama | GANAB G2AN KIAA0088 | DKPEETQGKAEKDEPGAWEEtFKTHSDSKPYGPMSVGLDFS |
| Q14C86 | S1012 | EPSD|PSP | GAPVD1 GAPEX5 KIAA1521 RAP6 | PFRKKEKQEKDKDDLGPDRFstLTDDPsPRLSAQAQVAEDI |
| Q14C86 | T1013 | EPSD|PSP | GAPVD1 GAPEX5 KIAA1521 RAP6 | FRKKEKQEKDKDDLGPDRFstLTDDPsPRLSAQAQVAEDIL |
| Q15056 | S14 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | _______MADFDtyDDRAyssFGGGRGsRGsAGGHGsRSQK |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15750 | S452 | SIGNOR|EPSD|PSP | TAB1 MAP3K7IP1 | PTLTNQsPTLTLQSTNTHTQssSSssDGGLFRSRPAHSLPP |
| Q15750 | S453 | SIGNOR|EPSD|PSP | TAB1 MAP3K7IP1 | TLTNQsPTLTLQSTNTHTQssSSssDGGLFRSRPAHSLPPG |
| Q15750 | S456 | SIGNOR|EPSD|PSP | TAB1 MAP3K7IP1 | NQsPTLTLQSTNTHTQssSSssDGGLFRSRPAHSLPPGEDG |
| Q15750 | S457 | SIGNOR|EPSD|PSP | TAB1 MAP3K7IP1 | QsPTLTLQSTNTHTQssSSssDGGLFRSRPAHSLPPGEDGR |
| Q15819 | T142 | Sugiyama | UBE2V2 MMS2 UEV2 | LRRLMMSKENMKLPQPPEGQtyNN_________________ |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16775 | T291 | Sugiyama | HAGH GLO2 HAGH1 | PFMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD___ |
| Q27J81 | S1204 | Sugiyama | INF2 C14orf151 C14orf173 | ALDtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKK |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5SQI0 | S237 | SIGNOR|EPSD|PSP | ATAT1 C6orf134 MEC17 Nbla00487 | AAPARKLPPKRAEGDIKPYSsSDREFLKVAVEPPWPLNRAP |
| Q6P589 | S3 | SIGNOR|PSP | TNFAIP8L2 | __________________MEsFSSKSLALQAEKKLLSKMAG |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q7Z3J3 | T1210 | Sugiyama | RGPD4 RGP4 | KLIQRAEEMKSGLKDFKTFLtNDQTKVTEEENKGsGtGAAG |
| Q86WV6 | S355 | SIGNOR | STING1 ERIS MITA STING TMEM173 | QEEKEEVTVGSLKTSAVPSTsTMsQEPELLIsGMEKPLPLR |
| Q8IVT5 | S406 | SIGNOR|EPSD|PSP | KSR1 KSR | KEAPACRISFLPLTRLRRtEsVPsDINNPVDRAAEPHFGtL |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WUI4 | S155 | SIGNOR|EPSD|PSP | HDAC7 HDAC7A | PPVPSLPSDPPEHFPLRKtVsEPNLKLRYKPKKSLERRKNP |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92598 | T365 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | TRIPAVKERIAKFFGKDISTtLNADEAVARGCALQCAILsP |
| Q92598 | Y641 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MIMQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQD |
| Q92598 | Y643 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQDHQ |
| Q96CT7 | T103 | Sugiyama | CCDC124 | GGKAPRVATSSKVTRAQIEDtLRRDHQLREAPDTAEKAKsH |
| Q96HE7 | T293 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | LEKKWGHNITEFQQRFDGILtEGEGPRRLKNLYFLYLIELR |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q99497 | T154 | Sugiyama | PARK7 | MNGGHytysENRVEKDGLILtSRGPGTSFEFALAIVEALNG |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99613 | Y884 | Sugiyama | EIF3C EIF3S8 | GsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRRGGY |
| Q99666 | T1209 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | KLIQRAEEMKSGLKDFKTFLtNDQTKVTEEENKGsGtGAAG |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q99959 | S82 | PSP | PKP2 | QtLARKGRssVGNGNLHRtssVPEyVyNLHLVENDFVGGRs |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BS26 | T155 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | yIRQQKSDPIQEIRDLAEIttLDRSKRNIIGYFEQKDSDNy |
| Q9BV20 | T363 | Sugiyama | MRI1 MRDI UNQ6390/PRO21135 | VFAPEELRtALTTTISSRDGtLDGPQM______________ |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C2 | T1323 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ELGVGQMDWGNNLGLRDLEVtCDPDsGGsQGLRGCGVGQMD |
| Q9H2G2 | T1233 | Sugiyama | SLK KIAA0204 STK2 | LNPStQsRISKFyPIPsLHstGs__________________ |
| Q9H2X6 | Y361 | PSP | HIPK2 | RVKVIDFGSAsHVSKAVCstyLQsRYyRAPEIILGLPFCEA |
| Q9H444 | T101 | Sugiyama | CHMP4B C20orf178 SHAX1 | QIDGtLstIEFQREALENANtNtEVLKNMGYAAKAMKAAHD |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UKS6 | T209 | Sugiyama | PACSIN3 | QERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQAFE |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ35 | S1102 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | EsPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFs |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9UQL6 | S259 | EPSD|PSP | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y295 | T62 | Sugiyama | DRG1 NEDD3 | LITPKGGGGGGPGEGFDVAKtGDARIGFVGFPSVGKSTLLS |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3F4 | T117 | Sugiyama | STRAP MAWD UNRIP | LAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEAEPK |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y5K6 | T465 | Sugiyama | CD2AP | LKLDsEQLPLRPKsVDFDsLtVRtsKEtDVVNFDDIASSEN |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 6.830683e-09 | 8.166 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.390166e-09 | 8.076 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.049985e-08 | 7.688 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.923712e-07 | 6.716 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.615841e-07 | 6.582 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.111000e-07 | 6.291 | 1 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.755678e-07 | 6.170 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.786235e-07 | 6.168 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.153534e-06 | 5.938 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.346661e-06 | 5.871 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.738785e-06 | 5.760 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.329961e-06 | 5.633 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.693098e-06 | 5.433 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.504279e-06 | 5.259 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.057353e-06 | 5.151 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 7.508367e-06 | 5.124 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.104201e-05 | 4.957 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.240345e-05 | 4.906 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.234530e-05 | 4.908 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.535551e-05 | 4.814 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.535551e-05 | 4.814 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.635999e-05 | 4.786 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.615023e-05 | 4.792 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.524442e-05 | 4.817 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.823000e-05 | 4.739 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.308356e-05 | 4.637 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.308356e-05 | 4.637 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.311481e-05 | 4.636 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.559179e-05 | 4.592 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.627314e-05 | 4.580 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.804823e-05 | 4.552 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.785101e-05 | 4.555 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.804823e-05 | 4.552 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.073144e-05 | 4.512 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.388986e-05 | 4.470 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.072991e-05 | 4.390 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.224895e-05 | 4.374 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.723160e-05 | 4.326 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.288216e-05 | 4.277 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.795214e-05 | 4.237 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.864025e-05 | 4.163 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.093996e-05 | 4.092 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.832982e-05 | 4.106 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.820689e-05 | 4.107 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.093996e-05 | 4.092 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.503968e-05 | 4.022 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.503968e-05 | 4.022 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.503968e-05 | 4.022 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.111431e-04 | 3.954 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.328911e-04 | 3.877 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.409016e-04 | 3.851 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.733882e-04 | 3.761 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.794369e-04 | 3.746 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.867040e-04 | 3.729 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.022725e-04 | 3.694 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.210281e-04 | 3.656 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.288981e-04 | 3.640 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.299928e-04 | 3.638 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.301423e-04 | 3.638 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.554505e-04 | 3.593 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.633274e-04 | 3.580 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.785109e-04 | 3.555 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.754761e-04 | 3.560 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.785109e-04 | 3.555 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.796207e-04 | 3.553 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.916243e-04 | 3.535 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.916243e-04 | 3.535 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.269722e-04 | 3.485 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.662081e-04 | 3.436 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.662681e-04 | 3.436 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.988580e-04 | 3.399 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.000212e-04 | 3.398 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.091781e-04 | 3.388 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.329663e-04 | 3.364 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.478950e-04 | 3.349 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.274787e-04 | 3.278 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.637188e-04 | 3.249 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.779623e-04 | 3.238 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.222475e-04 | 3.206 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.516481e-04 | 3.186 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.516481e-04 | 3.186 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.726775e-04 | 3.172 | 1 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.807408e-04 | 3.167 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.017728e-04 | 3.154 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.509894e-04 | 3.124 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.509894e-04 | 3.124 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.152081e-04 | 3.089 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.650856e-04 | 3.063 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.720760e-04 | 3.059 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.844478e-04 | 3.053 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 8.844478e-04 | 3.053 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.149833e-04 | 3.039 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.104711e-03 | 2.957 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.205719e-03 | 2.919 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.205719e-03 | 2.919 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.205719e-03 | 2.919 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.205719e-03 | 2.919 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.205719e-03 | 2.919 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.244305e-03 | 2.905 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.351915e-03 | 2.869 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.325088e-03 | 2.878 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.394948e-03 | 2.855 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.421020e-03 | 2.847 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.421020e-03 | 2.847 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.480130e-03 | 2.830 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.629784e-03 | 2.788 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.626305e-03 | 2.789 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.616730e-03 | 2.791 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.528186e-03 | 2.816 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.527332e-03 | 2.816 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.611295e-03 | 2.793 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.662400e-03 | 2.779 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.686445e-03 | 2.773 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.744957e-03 | 2.758 | 1 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.781368e-03 | 2.749 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.839114e-03 | 2.735 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.883240e-03 | 2.725 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.989517e-03 | 2.701 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.125243e-03 | 2.673 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.331904e-03 | 2.632 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.387273e-03 | 2.622 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.380707e-03 | 2.623 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.263866e-03 | 2.645 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.227835e-03 | 2.652 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.516990e-03 | 2.599 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.563433e-03 | 2.591 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.617198e-03 | 2.582 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.928954e-03 | 2.533 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.928954e-03 | 2.533 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.947577e-03 | 2.531 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.955316e-03 | 2.529 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.122922e-03 | 2.505 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.654196e-03 | 2.437 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.416079e-03 | 2.466 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.285260e-03 | 2.483 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.319578e-03 | 2.479 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.351410e-03 | 2.475 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.654196e-03 | 2.437 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.399295e-03 | 2.469 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.268369e-03 | 2.486 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.654196e-03 | 2.437 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.869271e-03 | 2.412 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.926064e-03 | 2.406 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.995360e-03 | 2.398 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.018651e-03 | 2.396 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.023872e-03 | 2.395 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.036398e-03 | 2.394 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.036398e-03 | 2.394 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.406089e-03 | 2.356 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.424111e-03 | 2.354 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.468176e-03 | 2.350 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.528233e-03 | 2.344 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.567937e-03 | 2.340 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.567937e-03 | 2.340 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.801507e-03 | 2.319 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.013235e-03 | 2.300 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.103987e-03 | 2.292 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.159857e-03 | 2.287 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.435607e-03 | 2.265 | 1 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.220687e-03 | 2.206 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.220687e-03 | 2.206 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.228309e-03 | 2.206 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.382809e-03 | 2.195 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.745992e-03 | 2.171 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.783014e-03 | 2.169 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.937377e-03 | 2.159 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.160629e-03 | 2.145 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.417166e-03 | 2.130 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.417166e-03 | 2.130 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 7.417166e-03 | 2.130 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.888303e-03 | 2.103 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.937374e-03 | 2.100 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 8.742702e-03 | 2.058 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.926154e-03 | 2.049 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.126460e-03 | 2.090 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.147582e-03 | 2.039 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.716165e-03 | 2.060 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.393137e-03 | 2.027 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.141672e-03 | 2.089 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.716165e-03 | 2.060 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.729384e-03 | 2.059 | 1 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.303374e-03 | 2.031 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.954840e-03 | 2.048 | 1 | 1 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.024355e-02 | 1.990 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.024355e-02 | 1.990 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.024355e-02 | 1.990 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.030521e-02 | 1.987 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.030521e-02 | 1.987 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.030521e-02 | 1.987 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.030521e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.030521e-02 | 1.987 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.030521e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.030521e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.030521e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.030521e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.030521e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.030521e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.030521e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.030521e-02 | 1.987 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.057633e-02 | 1.976 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.057633e-02 | 1.976 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.070205e-02 | 1.971 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.104183e-02 | 1.957 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.127715e-02 | 1.948 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.131662e-02 | 1.946 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.188555e-02 | 1.925 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.188555e-02 | 1.925 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.365782e-02 | 1.865 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.276658e-02 | 1.894 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.365782e-02 | 1.865 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.371269e-02 | 1.863 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.371269e-02 | 1.863 | 1 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.276658e-02 | 1.894 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.338795e-02 | 1.873 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.365782e-02 | 1.865 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.181945e-02 | 1.927 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.401813e-02 | 1.853 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.570848e-02 | 1.804 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.588784e-02 | 1.799 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.588784e-02 | 1.799 | 1 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.606772e-02 | 1.794 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.655044e-02 | 1.781 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.710407e-02 | 1.767 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.710407e-02 | 1.767 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.717452e-02 | 1.765 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.717452e-02 | 1.765 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.746347e-02 | 1.758 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.778916e-02 | 1.750 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.778916e-02 | 1.750 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.778916e-02 | 1.750 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.833312e-02 | 1.737 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.928942e-02 | 1.715 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.962289e-02 | 1.707 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.962289e-02 | 1.707 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.972671e-02 | 1.705 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.009735e-02 | 1.697 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.017003e-02 | 1.695 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.524500e-02 | 1.598 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.386999e-02 | 1.622 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.482232e-02 | 1.605 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.535784e-02 | 1.596 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.046070e-02 | 1.689 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.258168e-02 | 1.646 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.084143e-02 | 1.681 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.206931e-02 | 1.656 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.097475e-02 | 1.678 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.080766e-02 | 1.682 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.239002e-02 | 1.650 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.273733e-02 | 1.643 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.097475e-02 | 1.678 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.336768e-02 | 1.631 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.456659e-02 | 1.610 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.483545e-02 | 1.605 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.456659e-02 | 1.610 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.456659e-02 | 1.610 | 1 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.247590e-02 | 1.648 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.160338e-02 | 1.665 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.286473e-02 | 1.641 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.333875e-02 | 1.632 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.124296e-02 | 1.673 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.541590e-02 | 1.595 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.599887e-02 | 1.585 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.614247e-02 | 1.583 | 1 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.702892e-02 | 1.568 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.737529e-02 | 1.563 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.804586e-02 | 1.552 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.808967e-02 | 1.551 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 2.808967e-02 | 1.551 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.808967e-02 | 1.551 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.829001e-02 | 1.548 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.930954e-02 | 1.533 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.930954e-02 | 1.533 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.930954e-02 | 1.533 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 3.111756e-02 | 1.507 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.111756e-02 | 1.507 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.141164e-02 | 1.503 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.141164e-02 | 1.503 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.228184e-02 | 1.491 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.410248e-02 | 1.467 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.421743e-02 | 1.466 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.433011e-02 | 1.464 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.436923e-02 | 1.464 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.436923e-02 | 1.464 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.444988e-02 | 1.463 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 3.705416e-02 | 1.431 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 3.705416e-02 | 1.431 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 3.705416e-02 | 1.431 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.735550e-02 | 1.428 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.613773e-02 | 1.336 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.619528e-02 | 1.441 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.108739e-02 | 1.386 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.629448e-02 | 1.334 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.508303e-02 | 1.346 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.508303e-02 | 1.346 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.508303e-02 | 1.346 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.368152e-02 | 1.360 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.635629e-02 | 1.439 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.613773e-02 | 1.336 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.108739e-02 | 1.386 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.619528e-02 | 1.441 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.629448e-02 | 1.334 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.223495e-02 | 1.374 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.735550e-02 | 1.428 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.613773e-02 | 1.336 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.283792e-02 | 1.368 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.629448e-02 | 1.334 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.131254e-02 | 1.384 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.508303e-02 | 1.346 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.613773e-02 | 1.336 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.223495e-02 | 1.374 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.131254e-02 | 1.384 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.022543e-02 | 1.395 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.022543e-02 | 1.395 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.108860e-02 | 1.386 | 1 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.629448e-02 | 1.334 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.670731e-02 | 1.435 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.288967e-02 | 1.368 | 1 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.613773e-02 | 1.336 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 3.619528e-02 | 1.441 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 3.619528e-02 | 1.441 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.078508e-02 | 1.389 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.772826e-02 | 1.423 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.247507e-02 | 1.372 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.406285e-02 | 1.356 | 1 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.631394e-02 | 1.334 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.852879e-02 | 1.314 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.903942e-02 | 1.309 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.903942e-02 | 1.309 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.903942e-02 | 1.309 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.903942e-02 | 1.309 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.912160e-02 | 1.309 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.912160e-02 | 1.309 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.948962e-02 | 1.305 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.998155e-02 | 1.301 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.062184e-02 | 1.296 | 1 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.181049e-02 | 1.286 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.198136e-02 | 1.284 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.245632e-02 | 1.280 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.245632e-02 | 1.280 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.306341e-02 | 1.275 | 1 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.479188e-02 | 1.261 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.479188e-02 | 1.261 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.559081e-02 | 1.255 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.559081e-02 | 1.255 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.559081e-02 | 1.255 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.617046e-02 | 1.250 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.698719e-02 | 1.244 | 1 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.750664e-02 | 1.240 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.762847e-02 | 1.239 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.762847e-02 | 1.239 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.762847e-02 | 1.239 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.762847e-02 | 1.239 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.762847e-02 | 1.239 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.767679e-02 | 1.239 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.797154e-02 | 1.237 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.951215e-02 | 1.225 | 1 | 1 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.046794e-02 | 1.218 | 1 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.093161e-02 | 1.215 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.099990e-02 | 1.215 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.201492e-02 | 1.208 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.201492e-02 | 1.208 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.266717e-02 | 1.203 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.323296e-02 | 1.199 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.326184e-02 | 1.199 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.374074e-02 | 1.196 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.374074e-02 | 1.196 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.374074e-02 | 1.196 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.387568e-02 | 1.195 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.565315e-02 | 1.183 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.565315e-02 | 1.183 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.565315e-02 | 1.183 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.565315e-02 | 1.183 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.565315e-02 | 1.183 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.273749e-02 | 1.138 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 7.273749e-02 | 1.138 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 7.273749e-02 | 1.138 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 7.273749e-02 | 1.138 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.681412e-02 | 1.115 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.681412e-02 | 1.115 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.375686e-02 | 1.077 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.375686e-02 | 1.077 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.374457e-02 | 1.077 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.857166e-02 | 1.164 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.857166e-02 | 1.164 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.939776e-02 | 1.049 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.747754e-02 | 1.011 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.661585e-02 | 1.116 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.161208e-02 | 1.145 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.840534e-02 | 1.007 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.374457e-02 | 1.077 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.661585e-02 | 1.116 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 8.737719e-02 | 1.059 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.157180e-02 | 1.145 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.558087e-02 | 1.122 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.375686e-02 | 1.077 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.095733e-02 | 1.041 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.799419e-02 | 1.108 | 1 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.013893e-02 | 1.154 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 9.849605e-02 | 1.007 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.849605e-02 | 1.007 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.746323e-02 | 1.171 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.339038e-02 | 1.030 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.157180e-02 | 1.145 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.626678e-02 | 1.118 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.626678e-02 | 1.118 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.626678e-02 | 1.118 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.038241e-02 | 1.095 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.737719e-02 | 1.059 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.626678e-02 | 1.118 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.737719e-02 | 1.059 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.615894e-02 | 1.179 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.335894e-02 | 1.135 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.352469e-02 | 1.078 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.626678e-02 | 1.118 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.157180e-02 | 1.145 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.661585e-02 | 1.116 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 9.849605e-02 | 1.007 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.857166e-02 | 1.164 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.183342e-02 | 1.087 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.737719e-02 | 1.059 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.840534e-02 | 1.007 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.251997e-02 | 1.083 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 8.737719e-02 | 1.059 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.480924e-02 | 1.023 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.480924e-02 | 1.023 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.921232e-02 | 1.101 | 1 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.737719e-02 | 1.059 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.375686e-02 | 1.077 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.087594e-02 | 1.150 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.343394e-02 | 1.134 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.626678e-02 | 1.118 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.626678e-02 | 1.118 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 9.840534e-02 | 1.007 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.105835e-02 | 1.148 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.626678e-02 | 1.118 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.840534e-02 | 1.007 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.375686e-02 | 1.077 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 9.893311e-02 | 1.005 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 9.893311e-02 | 1.005 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 9.893311e-02 | 1.005 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.028236e-01 | 0.988 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.043753e-01 | 0.981 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.054465e-01 | 0.977 | 1 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.060904e-01 | 0.974 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.060904e-01 | 0.974 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.071006e-01 | 0.970 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.071006e-01 | 0.970 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.071006e-01 | 0.970 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 1.071888e-01 | 0.970 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.074066e-01 | 0.969 | 1 | 0 |
| Innate Immune System | R-HSA-168249 | 1.078346e-01 | 0.967 | 1 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.089824e-01 | 0.963 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.104106e-01 | 0.957 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 1.108864e-01 | 0.955 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.108864e-01 | 0.955 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.108864e-01 | 0.955 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.140019e-01 | 0.943 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 1.140019e-01 | 0.943 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.140019e-01 | 0.943 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.140019e-01 | 0.943 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.156313e-01 | 0.937 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.192403e-01 | 0.924 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.192988e-01 | 0.923 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.209647e-01 | 0.917 | 1 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.228918e-01 | 0.910 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.229332e-01 | 0.910 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.231919e-01 | 0.909 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.231919e-01 | 0.909 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.231919e-01 | 0.909 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.231919e-01 | 0.909 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.231919e-01 | 0.909 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.231919e-01 | 0.909 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.231919e-01 | 0.909 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.231919e-01 | 0.909 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.265369e-01 | 0.898 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.269507e-01 | 0.896 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.282973e-01 | 0.892 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.282973e-01 | 0.892 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.294118e-01 | 0.888 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.295808e-01 | 0.887 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.304605e-01 | 0.885 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.304605e-01 | 0.885 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.358072e-01 | 0.867 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.358072e-01 | 0.867 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.358072e-01 | 0.867 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.358072e-01 | 0.867 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.358072e-01 | 0.867 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.358072e-01 | 0.867 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.360292e-01 | 0.866 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.389856e-01 | 0.857 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.389856e-01 | 0.857 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.389856e-01 | 0.857 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.394257e-01 | 0.856 | 1 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 1.401923e-01 | 0.853 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.401923e-01 | 0.853 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.401923e-01 | 0.853 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 1.720595e-01 | 0.764 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 1.720595e-01 | 0.764 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 1.720595e-01 | 0.764 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 1.720595e-01 | 0.764 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.027475e-01 | 0.693 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.027475e-01 | 0.693 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.027475e-01 | 0.693 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.322998e-01 | 0.634 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 2.322998e-01 | 0.634 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.322998e-01 | 0.634 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.322998e-01 | 0.634 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.607585e-01 | 0.584 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 2.607585e-01 | 0.584 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 2.022241e-01 | 0.694 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.297491e-01 | 0.639 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.436068e-01 | 0.613 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.436068e-01 | 0.613 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.436068e-01 | 0.613 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.436068e-01 | 0.613 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.436068e-01 | 0.613 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.496614e-01 | 0.825 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.852888e-01 | 0.545 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.852888e-01 | 0.545 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.226135e-01 | 0.652 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.933832e-01 | 0.714 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.699543e-01 | 0.569 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.442221e-01 | 0.841 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.904417e-01 | 0.720 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.104012e-01 | 0.677 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.748030e-01 | 0.757 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.159466e-01 | 0.666 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.852888e-01 | 0.545 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.250459e-01 | 0.648 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.713972e-01 | 0.566 | 1 | 1 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.852888e-01 | 0.545 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.073100e-01 | 0.683 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.027475e-01 | 0.693 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.814359e-01 | 0.741 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.814359e-01 | 0.741 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.027475e-01 | 0.693 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 2.322998e-01 | 0.634 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.324458e-01 | 0.634 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.027475e-01 | 0.693 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.027475e-01 | 0.693 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 2.607585e-01 | 0.584 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.841283e-01 | 0.735 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.485829e-01 | 0.605 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.443770e-01 | 0.841 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.443770e-01 | 0.841 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.443770e-01 | 0.841 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.710304e-01 | 0.767 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.710304e-01 | 0.767 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.877889e-01 | 0.726 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.935838e-01 | 0.713 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.637913e-01 | 0.786 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.637913e-01 | 0.786 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.322998e-01 | 0.634 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.322998e-01 | 0.634 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.607585e-01 | 0.584 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.607585e-01 | 0.584 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.618105e-01 | 0.791 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.618105e-01 | 0.791 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.841283e-01 | 0.735 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.226135e-01 | 0.652 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.841283e-01 | 0.735 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.794999e-01 | 0.746 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.815111e-01 | 0.551 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.821072e-01 | 0.740 | 1 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.424179e-01 | 0.615 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.551556e-01 | 0.593 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.027475e-01 | 0.693 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.436068e-01 | 0.613 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.637913e-01 | 0.786 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.783788e-01 | 0.749 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.795619e-01 | 0.746 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.227293e-01 | 0.652 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.031567e-01 | 0.692 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.324771e-01 | 0.634 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.618105e-01 | 0.791 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.506962e-01 | 0.822 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.654019e-01 | 0.781 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.128367e-01 | 0.672 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 1.720595e-01 | 0.764 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.027475e-01 | 0.693 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.322998e-01 | 0.634 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 1.486925e-01 | 0.828 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.618105e-01 | 0.791 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.751266e-01 | 0.757 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.387879e-01 | 0.622 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.511262e-01 | 0.600 | 1 | 1 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.476933e-01 | 0.831 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.010288e-01 | 0.697 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.649513e-01 | 0.577 | 1 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.624926e-01 | 0.581 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.607585e-01 | 0.584 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.637913e-01 | 0.786 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.732098e-01 | 0.564 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.453886e-01 | 0.837 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.696210e-01 | 0.771 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.877889e-01 | 0.726 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.629449e-01 | 0.580 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.573617e-01 | 0.589 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.436068e-01 | 0.613 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.022241e-01 | 0.694 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.699543e-01 | 0.569 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.946744e-01 | 0.711 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 1.720595e-01 | 0.764 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.027475e-01 | 0.693 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.322998e-01 | 0.634 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.607585e-01 | 0.584 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.618105e-01 | 0.791 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.886079e-01 | 0.724 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.574966e-01 | 0.589 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.713972e-01 | 0.566 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 2.726084e-01 | 0.564 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.649513e-01 | 0.577 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.512077e-01 | 0.820 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.978759e-01 | 0.704 | 1 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.574966e-01 | 0.589 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.624926e-01 | 0.581 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.942210e-01 | 0.712 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.618105e-01 | 0.791 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.945193e-01 | 0.711 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.945193e-01 | 0.711 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.713972e-01 | 0.566 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.852888e-01 | 0.545 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.446560e-01 | 0.611 | 1 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.427806e-01 | 0.845 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.088168e-01 | 0.680 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.607585e-01 | 0.584 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 1.886079e-01 | 0.724 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.841283e-01 | 0.735 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.852888e-01 | 0.545 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.827645e-01 | 0.549 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.827645e-01 | 0.549 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.159466e-01 | 0.666 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.159466e-01 | 0.666 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.031567e-01 | 0.692 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.726084e-01 | 0.564 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.803071e-01 | 0.744 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.728838e-01 | 0.762 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.607585e-01 | 0.584 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.436068e-01 | 0.613 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.935838e-01 | 0.713 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.827645e-01 | 0.549 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.751650e-01 | 0.757 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.732098e-01 | 0.564 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.433227e-01 | 0.844 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.618105e-01 | 0.791 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.565723e-01 | 0.805 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 2.436068e-01 | 0.613 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.886079e-01 | 0.724 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 2.485829e-01 | 0.605 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 2.226135e-01 | 0.652 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.886079e-01 | 0.724 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 2.165611e-01 | 0.664 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.573617e-01 | 0.589 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.352046e-01 | 0.629 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.159466e-01 | 0.666 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.486925e-01 | 0.828 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.027879e-01 | 0.693 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 1.668110e-01 | 0.778 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 2.860575e-01 | 0.544 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.881638e-01 | 0.540 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.881638e-01 | 0.540 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 2.881638e-01 | 0.540 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 2.881638e-01 | 0.540 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.881638e-01 | 0.540 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 2.881638e-01 | 0.540 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.881638e-01 | 0.540 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.891145e-01 | 0.539 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.914716e-01 | 0.535 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.929525e-01 | 0.533 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.929525e-01 | 0.533 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.991529e-01 | 0.524 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.991529e-01 | 0.524 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.991529e-01 | 0.524 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.020433e-01 | 0.520 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.033378e-01 | 0.518 | 1 | 1 |
| Deadenylation of mRNA | R-HSA-429947 | 3.129727e-01 | 0.504 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 3.129727e-01 | 0.504 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.129727e-01 | 0.504 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.133913e-01 | 0.504 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.145548e-01 | 0.502 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.145548e-01 | 0.502 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.145548e-01 | 0.502 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.145548e-01 | 0.502 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.145548e-01 | 0.502 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.145548e-01 | 0.502 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.145548e-01 | 0.502 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.145548e-01 | 0.502 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.145548e-01 | 0.502 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.145548e-01 | 0.502 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.204573e-01 | 0.494 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.234956e-01 | 0.490 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.236264e-01 | 0.490 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.236264e-01 | 0.490 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.236264e-01 | 0.490 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.267322e-01 | 0.486 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.267322e-01 | 0.486 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.267322e-01 | 0.486 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.267322e-01 | 0.486 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.338620e-01 | 0.476 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 3.338620e-01 | 0.476 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 3.338620e-01 | 0.476 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.338620e-01 | 0.476 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.399689e-01 | 0.469 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.399689e-01 | 0.469 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.399689e-01 | 0.469 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.399689e-01 | 0.469 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.399689e-01 | 0.469 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.399689e-01 | 0.469 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.399689e-01 | 0.469 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.399689e-01 | 0.469 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.399689e-01 | 0.469 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.399689e-01 | 0.469 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.399689e-01 | 0.469 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.399689e-01 | 0.469 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.399689e-01 | 0.469 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.404171e-01 | 0.468 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.404171e-01 | 0.468 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 3.404171e-01 | 0.468 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.404268e-01 | 0.468 | 1 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.440908e-01 | 0.463 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 3.440908e-01 | 0.463 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.489043e-01 | 0.457 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.540140e-01 | 0.451 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.540140e-01 | 0.451 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.540140e-01 | 0.451 | 1 | 1 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.540140e-01 | 0.451 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.540140e-01 | 0.451 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.540140e-01 | 0.451 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.546266e-01 | 0.450 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.573842e-01 | 0.447 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.573842e-01 | 0.447 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.577264e-01 | 0.446 | 1 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.644422e-01 | 0.438 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.644422e-01 | 0.438 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.644422e-01 | 0.438 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.644422e-01 | 0.438 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.644422e-01 | 0.438 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 3.644422e-01 | 0.438 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.644422e-01 | 0.438 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.644422e-01 | 0.438 | 1 | 1 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.644422e-01 | 0.438 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.644422e-01 | 0.438 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.644422e-01 | 0.438 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.644422e-01 | 0.438 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.644422e-01 | 0.438 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.644422e-01 | 0.438 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.644422e-01 | 0.438 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.644422e-01 | 0.438 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.644422e-01 | 0.438 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.644422e-01 | 0.438 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.645009e-01 | 0.438 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.658625e-01 | 0.437 | 1 | 1 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.658625e-01 | 0.437 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 3.675106e-01 | 0.435 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.675106e-01 | 0.435 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.675106e-01 | 0.435 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.743352e-01 | 0.427 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 3.746692e-01 | 0.426 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.790011e-01 | 0.421 | 1 | 1 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.808957e-01 | 0.419 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.808957e-01 | 0.419 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.808957e-01 | 0.419 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.808957e-01 | 0.419 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.808957e-01 | 0.419 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.808957e-01 | 0.419 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.808957e-01 | 0.419 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.863994e-01 | 0.413 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.863994e-01 | 0.413 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.880095e-01 | 0.411 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.880095e-01 | 0.411 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.880095e-01 | 0.411 | 1 | 1 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 3.880095e-01 | 0.411 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.880095e-01 | 0.411 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.880095e-01 | 0.411 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 3.880095e-01 | 0.411 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.880095e-01 | 0.411 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.941590e-01 | 0.404 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.941590e-01 | 0.404 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.941590e-01 | 0.404 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.949019e-01 | 0.404 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.949019e-01 | 0.404 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.996818e-01 | 0.398 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.049549e-01 | 0.393 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.049549e-01 | 0.393 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.072912e-01 | 0.390 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.072912e-01 | 0.390 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.072912e-01 | 0.390 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.072912e-01 | 0.390 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.072912e-01 | 0.390 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.080947e-01 | 0.389 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.080947e-01 | 0.389 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.107042e-01 | 0.386 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.107042e-01 | 0.386 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.107042e-01 | 0.386 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.107042e-01 | 0.386 | 1 | 1 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.107042e-01 | 0.386 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.107042e-01 | 0.386 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.149585e-01 | 0.382 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.159185e-01 | 0.381 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.192627e-01 | 0.378 | 1 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.202838e-01 | 0.376 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.249076e-01 | 0.372 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.249076e-01 | 0.372 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.325587e-01 | 0.364 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.325587e-01 | 0.364 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.325587e-01 | 0.364 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.325587e-01 | 0.364 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.325587e-01 | 0.364 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.325587e-01 | 0.364 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.325587e-01 | 0.364 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.325587e-01 | 0.364 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.325587e-01 | 0.364 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.325587e-01 | 0.364 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.325587e-01 | 0.364 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.325587e-01 | 0.364 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.325587e-01 | 0.364 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.331291e-01 | 0.363 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.331291e-01 | 0.363 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.331291e-01 | 0.363 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.331291e-01 | 0.363 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.331291e-01 | 0.363 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.331781e-01 | 0.363 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.347976e-01 | 0.362 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.347976e-01 | 0.362 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.347976e-01 | 0.362 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.347976e-01 | 0.362 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.347976e-01 | 0.362 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.347976e-01 | 0.362 | 1 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 4.386042e-01 | 0.358 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 4.386042e-01 | 0.358 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.458202e-01 | 0.351 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.458202e-01 | 0.351 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.458202e-01 | 0.351 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.474795e-01 | 0.349 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.489284e-01 | 0.348 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.536040e-01 | 0.343 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.536040e-01 | 0.343 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.536040e-01 | 0.343 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.536040e-01 | 0.343 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.536040e-01 | 0.343 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.536040e-01 | 0.343 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.536040e-01 | 0.343 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.536040e-01 | 0.343 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.536040e-01 | 0.343 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.536040e-01 | 0.343 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.536040e-01 | 0.343 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.536040e-01 | 0.343 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.536040e-01 | 0.343 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.536040e-01 | 0.343 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.536040e-01 | 0.343 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.536040e-01 | 0.343 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.536040e-01 | 0.343 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.536040e-01 | 0.343 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.536040e-01 | 0.343 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.536040e-01 | 0.343 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.536040e-01 | 0.343 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.543818e-01 | 0.343 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.549625e-01 | 0.342 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.583508e-01 | 0.339 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.583508e-01 | 0.339 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.583508e-01 | 0.339 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.583508e-01 | 0.339 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.583508e-01 | 0.339 | 1 | 1 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.583508e-01 | 0.339 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 4.609884e-01 | 0.336 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.707154e-01 | 0.327 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.707154e-01 | 0.327 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.729795e-01 | 0.325 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.736777e-01 | 0.325 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.736777e-01 | 0.325 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.736777e-01 | 0.325 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.736777e-01 | 0.325 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.736777e-01 | 0.325 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.736777e-01 | 0.325 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.738700e-01 | 0.324 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.738700e-01 | 0.324 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.738700e-01 | 0.324 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.738700e-01 | 0.324 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.738700e-01 | 0.324 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.738700e-01 | 0.324 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.738700e-01 | 0.324 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.738700e-01 | 0.324 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.738700e-01 | 0.324 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.738700e-01 | 0.324 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.738700e-01 | 0.324 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 4.829091e-01 | 0.316 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.832081e-01 | 0.316 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.893914e-01 | 0.310 | 1 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.926555e-01 | 0.307 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.926555e-01 | 0.307 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.933856e-01 | 0.307 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.933856e-01 | 0.307 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.933856e-01 | 0.307 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.933856e-01 | 0.307 | 1 | 1 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.933856e-01 | 0.307 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.933856e-01 | 0.307 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.933856e-01 | 0.307 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.933856e-01 | 0.307 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.933856e-01 | 0.307 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.933856e-01 | 0.307 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 4.933856e-01 | 0.307 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.933856e-01 | 0.307 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.933856e-01 | 0.307 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.949276e-01 | 0.305 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.004394e-01 | 0.301 | 1 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.020167e-01 | 0.299 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.063304e-01 | 0.296 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.063800e-01 | 0.296 | 1 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.067671e-01 | 0.295 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.067671e-01 | 0.295 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.067671e-01 | 0.295 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.067671e-01 | 0.295 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.121783e-01 | 0.291 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.121783e-01 | 0.291 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.121783e-01 | 0.291 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.121783e-01 | 0.291 | 1 | 1 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 5.121783e-01 | 0.291 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.121783e-01 | 0.291 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.121783e-01 | 0.291 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.121783e-01 | 0.291 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.121783e-01 | 0.291 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.121783e-01 | 0.291 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.142077e-01 | 0.289 | 1 | 1 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.181469e-01 | 0.286 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.184243e-01 | 0.285 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.184243e-01 | 0.285 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.184243e-01 | 0.285 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.271898e-01 | 0.278 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.298965e-01 | 0.276 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.298965e-01 | 0.276 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.298965e-01 | 0.276 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.302751e-01 | 0.275 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.302751e-01 | 0.275 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.302751e-01 | 0.275 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.302751e-01 | 0.275 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.302751e-01 | 0.275 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.302751e-01 | 0.275 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.302751e-01 | 0.275 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.302751e-01 | 0.275 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.302751e-01 | 0.275 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.302751e-01 | 0.275 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.372159e-01 | 0.270 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.374818e-01 | 0.270 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.374818e-01 | 0.270 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.385436e-01 | 0.269 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.411814e-01 | 0.267 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.451144e-01 | 0.264 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.477016e-01 | 0.261 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.477016e-01 | 0.261 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.477016e-01 | 0.261 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.477016e-01 | 0.261 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 5.477016e-01 | 0.261 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.477016e-01 | 0.261 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.477016e-01 | 0.261 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.477016e-01 | 0.261 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.477016e-01 | 0.261 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.477016e-01 | 0.261 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.477016e-01 | 0.261 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.506946e-01 | 0.259 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.522771e-01 | 0.258 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.522771e-01 | 0.258 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.522771e-01 | 0.258 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.532977e-01 | 0.257 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.631820e-01 | 0.249 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.640418e-01 | 0.249 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.644826e-01 | 0.248 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.644826e-01 | 0.248 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.649082e-01 | 0.248 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.734896e-01 | 0.241 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.734896e-01 | 0.241 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.738951e-01 | 0.241 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.749744e-01 | 0.240 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.771856e-01 | 0.239 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.806420e-01 | 0.236 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.806420e-01 | 0.236 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.806420e-01 | 0.236 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.806420e-01 | 0.236 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.806420e-01 | 0.236 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.844156e-01 | 0.233 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.844156e-01 | 0.233 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.894826e-01 | 0.230 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.894826e-01 | 0.230 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.947430e-01 | 0.226 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.962028e-01 | 0.225 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.962028e-01 | 0.225 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.962028e-01 | 0.225 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.962028e-01 | 0.225 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.962028e-01 | 0.225 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.962028e-01 | 0.225 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 5.962028e-01 | 0.225 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.962028e-01 | 0.225 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.962028e-01 | 0.225 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.962028e-01 | 0.225 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.962028e-01 | 0.225 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.962028e-01 | 0.225 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.962028e-01 | 0.225 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 5.965012e-01 | 0.224 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.973040e-01 | 0.224 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.985919e-01 | 0.223 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.048772e-01 | 0.218 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.048772e-01 | 0.218 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.088152e-01 | 0.216 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.111871e-01 | 0.214 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.111871e-01 | 0.214 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.111871e-01 | 0.214 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.111871e-01 | 0.214 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 6.111871e-01 | 0.214 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.111871e-01 | 0.214 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.111871e-01 | 0.214 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.111871e-01 | 0.214 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.147803e-01 | 0.211 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.245667e-01 | 0.204 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.256162e-01 | 0.204 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.256162e-01 | 0.204 | 1 | 1 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.256162e-01 | 0.204 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.256162e-01 | 0.204 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.256162e-01 | 0.204 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 6.304318e-01 | 0.200 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 6.305231e-01 | 0.200 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 6.305231e-01 | 0.200 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.341229e-01 | 0.198 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.395107e-01 | 0.194 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.395107e-01 | 0.194 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.395107e-01 | 0.194 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.395107e-01 | 0.194 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.439573e-01 | 0.191 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.458155e-01 | 0.190 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.475392e-01 | 0.189 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 6.498592e-01 | 0.187 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.513539e-01 | 0.186 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.526625e-01 | 0.185 | 1 | 1 |
| Meiotic recombination | R-HSA-912446 | 6.526625e-01 | 0.185 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.528903e-01 | 0.185 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.528903e-01 | 0.185 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.528903e-01 | 0.185 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.528903e-01 | 0.185 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.529817e-01 | 0.185 | 1 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.532918e-01 | 0.185 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 6.553225e-01 | 0.184 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.571478e-01 | 0.182 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.574710e-01 | 0.182 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.616481e-01 | 0.179 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.616481e-01 | 0.179 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.635327e-01 | 0.178 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.638355e-01 | 0.178 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.638355e-01 | 0.178 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.638355e-01 | 0.178 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.651007e-01 | 0.177 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.657742e-01 | 0.177 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.657742e-01 | 0.177 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.657742e-01 | 0.177 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.657742e-01 | 0.177 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.657742e-01 | 0.177 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 6.657742e-01 | 0.177 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.657742e-01 | 0.177 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 6.657742e-01 | 0.177 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 6.657742e-01 | 0.177 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.701190e-01 | 0.174 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 6.781806e-01 | 0.169 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.781806e-01 | 0.169 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.781806e-01 | 0.169 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.781806e-01 | 0.169 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.781806e-01 | 0.169 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.790579e-01 | 0.168 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.851792e-01 | 0.164 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.880672e-01 | 0.162 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 6.884820e-01 | 0.162 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.901271e-01 | 0.161 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.901271e-01 | 0.161 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.901271e-01 | 0.161 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.901271e-01 | 0.161 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.901271e-01 | 0.161 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.901271e-01 | 0.161 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.901271e-01 | 0.161 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.901271e-01 | 0.161 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.905959e-01 | 0.161 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.957301e-01 | 0.158 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.003162e-01 | 0.155 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.016310e-01 | 0.154 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.016310e-01 | 0.154 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.016310e-01 | 0.154 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.016310e-01 | 0.154 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.016310e-01 | 0.154 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.016310e-01 | 0.154 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.016310e-01 | 0.154 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.037943e-01 | 0.153 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.061108e-01 | 0.151 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.116798e-01 | 0.148 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.116798e-01 | 0.148 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.127084e-01 | 0.147 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.127084e-01 | 0.147 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.127084e-01 | 0.147 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.127084e-01 | 0.147 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.127084e-01 | 0.147 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.127084e-01 | 0.147 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.127084e-01 | 0.147 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.127084e-01 | 0.147 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.193888e-01 | 0.143 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.193888e-01 | 0.143 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.225037e-01 | 0.141 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.230054e-01 | 0.141 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.230054e-01 | 0.141 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.233752e-01 | 0.141 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.233752e-01 | 0.141 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.233752e-01 | 0.141 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.233752e-01 | 0.141 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.233752e-01 | 0.141 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.233752e-01 | 0.141 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 7.233752e-01 | 0.141 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.269236e-01 | 0.139 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.280582e-01 | 0.138 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.280582e-01 | 0.138 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.328553e-01 | 0.135 | 1 | 0 |
| mRNA Capping | R-HSA-72086 | 7.336466e-01 | 0.135 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.336466e-01 | 0.135 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.338623e-01 | 0.134 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.349128e-01 | 0.134 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.412444e-01 | 0.130 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.414797e-01 | 0.130 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.435372e-01 | 0.129 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.435372e-01 | 0.129 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.435372e-01 | 0.129 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.435372e-01 | 0.129 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.435372e-01 | 0.129 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.435372e-01 | 0.129 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.435372e-01 | 0.129 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.530611e-01 | 0.123 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.551925e-01 | 0.122 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.622319e-01 | 0.118 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.622319e-01 | 0.118 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.622319e-01 | 0.118 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.710626e-01 | 0.113 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.710626e-01 | 0.113 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.713089e-01 | 0.113 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.749891e-01 | 0.111 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.795659e-01 | 0.108 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.795659e-01 | 0.108 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.795659e-01 | 0.108 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.795659e-01 | 0.108 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.841659e-01 | 0.106 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.845039e-01 | 0.105 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.872944e-01 | 0.104 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.877539e-01 | 0.104 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.877539e-01 | 0.104 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.877539e-01 | 0.104 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.877539e-01 | 0.104 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.877539e-01 | 0.104 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.877539e-01 | 0.104 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.932222e-01 | 0.101 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.940272e-01 | 0.100 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.956382e-01 | 0.099 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.956382e-01 | 0.099 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 7.956382e-01 | 0.099 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.989706e-01 | 0.097 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 7.990037e-01 | 0.097 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.032300e-01 | 0.095 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.032300e-01 | 0.095 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.046416e-01 | 0.094 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.105403e-01 | 0.091 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.105403e-01 | 0.091 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.105403e-01 | 0.091 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.105403e-01 | 0.091 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.105403e-01 | 0.091 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.105403e-01 | 0.091 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.134769e-01 | 0.090 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.134769e-01 | 0.090 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 8.175795e-01 | 0.087 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.203105e-01 | 0.086 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.207201e-01 | 0.086 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.243575e-01 | 0.084 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.243575e-01 | 0.084 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.243575e-01 | 0.084 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.243575e-01 | 0.084 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.258102e-01 | 0.083 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.258102e-01 | 0.083 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.308841e-01 | 0.080 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.308841e-01 | 0.080 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.308841e-01 | 0.080 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.308841e-01 | 0.080 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.308841e-01 | 0.080 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.308841e-01 | 0.080 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.308841e-01 | 0.080 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.308841e-01 | 0.080 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 8.308841e-01 | 0.080 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.308841e-01 | 0.080 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.348413e-01 | 0.078 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.356022e-01 | 0.078 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.356022e-01 | 0.078 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.356022e-01 | 0.078 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.371685e-01 | 0.077 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.371685e-01 | 0.077 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.371685e-01 | 0.077 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.371685e-01 | 0.077 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.376462e-01 | 0.077 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.406518e-01 | 0.075 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.432198e-01 | 0.074 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.432198e-01 | 0.074 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.432198e-01 | 0.074 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 8.432198e-01 | 0.074 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.432198e-01 | 0.074 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.432198e-01 | 0.074 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.480161e-01 | 0.072 | 1 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.490466e-01 | 0.071 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.490466e-01 | 0.071 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.490466e-01 | 0.071 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.507100e-01 | 0.070 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.546571e-01 | 0.068 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.546571e-01 | 0.068 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.579403e-01 | 0.067 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.599768e-01 | 0.066 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.600595e-01 | 0.065 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.600595e-01 | 0.065 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.600595e-01 | 0.065 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.650698e-01 | 0.063 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.652613e-01 | 0.063 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.652613e-01 | 0.063 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.652613e-01 | 0.063 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.652613e-01 | 0.063 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.660725e-01 | 0.062 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.660725e-01 | 0.062 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.702701e-01 | 0.060 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.702701e-01 | 0.060 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.702701e-01 | 0.060 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.702701e-01 | 0.060 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.737757e-01 | 0.059 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.737757e-01 | 0.059 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.750930e-01 | 0.058 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.797369e-01 | 0.056 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.810693e-01 | 0.055 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 8.810693e-01 | 0.055 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.810693e-01 | 0.055 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.832617e-01 | 0.054 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.842084e-01 | 0.053 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 8.842084e-01 | 0.053 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.851610e-01 | 0.053 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.864131e-01 | 0.052 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.864131e-01 | 0.052 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.885140e-01 | 0.051 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.916163e-01 | 0.050 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.920030e-01 | 0.050 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.926596e-01 | 0.049 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.945015e-01 | 0.048 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.945015e-01 | 0.048 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.966097e-01 | 0.047 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.966514e-01 | 0.047 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.966514e-01 | 0.047 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.966514e-01 | 0.047 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.966514e-01 | 0.047 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.976320e-01 | 0.047 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.984699e-01 | 0.046 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.984699e-01 | 0.046 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.984699e-01 | 0.046 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.004949e-01 | 0.046 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.004949e-01 | 0.046 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.004949e-01 | 0.046 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.004949e-01 | 0.046 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.006759e-01 | 0.045 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.036353e-01 | 0.044 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.065122e-01 | 0.043 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.077592e-01 | 0.042 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.077592e-01 | 0.042 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.077592e-01 | 0.042 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.093087e-01 | 0.041 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.093087e-01 | 0.041 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.093087e-01 | 0.041 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.111903e-01 | 0.040 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.111903e-01 | 0.040 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.120267e-01 | 0.040 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.120267e-01 | 0.040 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.144939e-01 | 0.039 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.146683e-01 | 0.039 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.176749e-01 | 0.037 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.176749e-01 | 0.037 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.178790e-01 | 0.037 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.207377e-01 | 0.036 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.207377e-01 | 0.036 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.207377e-01 | 0.036 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.236867e-01 | 0.034 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.236867e-01 | 0.034 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.236867e-01 | 0.034 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.245078e-01 | 0.034 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.265262e-01 | 0.033 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.265262e-01 | 0.033 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.267951e-01 | 0.033 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.284716e-01 | 0.032 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.290170e-01 | 0.032 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.318926e-01 | 0.031 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.320212e-01 | 0.031 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.332709e-01 | 0.030 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.344273e-01 | 0.029 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.368677e-01 | 0.028 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.392021e-01 | 0.027 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.392175e-01 | 0.027 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.410655e-01 | 0.026 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.414799e-01 | 0.026 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.414799e-01 | 0.026 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.436583e-01 | 0.025 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.436583e-01 | 0.025 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.438913e-01 | 0.025 | 1 | 1 |
| Antimicrobial peptides | R-HSA-6803157 | 9.463356e-01 | 0.024 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.477752e-01 | 0.023 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.477752e-01 | 0.023 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.477752e-01 | 0.023 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.479904e-01 | 0.023 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.479904e-01 | 0.023 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.497195e-01 | 0.022 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.497195e-01 | 0.022 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.533942e-01 | 0.021 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.543835e-01 | 0.020 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.550902e-01 | 0.020 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.551297e-01 | 0.020 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.551297e-01 | 0.020 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.568007e-01 | 0.019 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.568007e-01 | 0.019 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.599585e-01 | 0.018 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.628859e-01 | 0.016 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.632568e-01 | 0.016 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.655996e-01 | 0.015 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.655996e-01 | 0.015 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.656375e-01 | 0.015 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.681152e-01 | 0.014 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.686774e-01 | 0.014 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.693033e-01 | 0.014 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.693033e-01 | 0.014 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.693033e-01 | 0.014 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.715484e-01 | 0.013 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.726087e-01 | 0.012 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.736296e-01 | 0.012 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.741699e-01 | 0.011 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.750885e-01 | 0.011 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.770092e-01 | 0.010 | 1 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.805412e-01 | 0.009 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.819655e-01 | 0.008 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.821259e-01 | 0.008 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.826381e-01 | 0.008 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.839091e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.845093e-01 | 0.007 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.850871e-01 | 0.007 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.866948e-01 | 0.006 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.873949e-01 | 0.006 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.875275e-01 | 0.005 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.881294e-01 | 0.005 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.881995e-01 | 0.005 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.885724e-01 | 0.005 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.895487e-01 | 0.005 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.898048e-01 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.901854e-01 | 0.004 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.920746e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.924805e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.924805e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.930317e-01 | 0.003 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.944548e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.946214e-01 | 0.002 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.957559e-01 | 0.002 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.962114e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.972071e-01 | 0.001 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.977782e-01 | 0.001 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.979484e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.980926e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.981324e-01 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.983311e-01 | 0.001 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.984239e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.987934e-01 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.988157e-01 | 0.001 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.990876e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.991110e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.991903e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999261e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999669e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999716e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999933e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999986e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999990e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.776357e-15 | 14.750 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.331468e-15 | 14.632 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.775558e-15 | 14.557 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.997602e-15 | 14.523 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-14 | 13.955 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.298961e-14 | 13.886 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.609823e-14 | 13.793 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.720846e-14 | 13.764 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.697842e-14 | 13.569 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.764455e-14 | 13.558 | 1 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.618528e-14 | 13.335 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.024736e-13 | 12.989 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.989031e-13 | 12.399 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.233103e-13 | 12.141 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.898127e-13 | 12.102 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.654188e-13 | 12.063 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.797784e-12 | 11.745 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.498335e-12 | 11.602 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.874700e-12 | 11.541 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.859357e-12 | 11.413 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.784129e-12 | 11.169 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.516154e-11 | 10.819 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.516154e-11 | 10.819 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.730283e-11 | 10.762 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.018219e-11 | 10.520 | 1 | 0 |
| Immune System | R-HSA-168256 | 3.498646e-11 | 10.456 | 1 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.104188e-10 | 9.957 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.702846e-10 | 9.568 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.892016e-10 | 9.539 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.964539e-10 | 9.528 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.156553e-10 | 9.501 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.128510e-10 | 9.505 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.437338e-10 | 9.464 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.749817e-10 | 9.426 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.686945e-10 | 9.329 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.150895e-10 | 9.288 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.467971e-10 | 9.262 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.725095e-10 | 9.172 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.053408e-10 | 9.152 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.128489e-10 | 9.147 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.013156e-09 | 8.994 | 1 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.158506e-09 | 8.936 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.207364e-09 | 8.918 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.381933e-09 | 8.860 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.498886e-09 | 8.824 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.684529e-09 | 8.774 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.829993e-09 | 8.738 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.820653e-09 | 8.740 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.887515e-09 | 8.724 | 1 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.891817e-09 | 8.723 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.438216e-09 | 8.613 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.512388e-09 | 8.600 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.325544e-09 | 8.478 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.507798e-09 | 8.455 | 1 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.892775e-09 | 8.410 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.219053e-09 | 8.375 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.002895e-09 | 8.222 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.699879e-09 | 8.013 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.022414e-08 | 7.990 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.140876e-08 | 7.943 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.250234e-08 | 7.903 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.283946e-08 | 7.891 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.283946e-08 | 7.891 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.328317e-08 | 7.877 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.447772e-08 | 7.839 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.683490e-08 | 7.774 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.727138e-08 | 7.763 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.810957e-08 | 7.742 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.935435e-08 | 7.713 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.208671e-08 | 7.656 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.578444e-08 | 7.589 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.545735e-08 | 7.594 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.803216e-08 | 7.552 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.495340e-08 | 7.457 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.560510e-08 | 7.448 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.145558e-08 | 7.382 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.185324e-08 | 7.378 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.929460e-08 | 7.307 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.183306e-08 | 7.285 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.244010e-08 | 7.280 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.083751e-08 | 7.294 | 1 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.343554e-08 | 7.272 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.025601e-08 | 7.096 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.688636e-08 | 7.014 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.711669e-08 | 7.013 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.079956e-07 | 6.967 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.163937e-07 | 6.934 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.183071e-07 | 6.927 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.247714e-07 | 6.904 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.372647e-07 | 6.862 | 1 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.374613e-07 | 6.862 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.374613e-07 | 6.862 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.485551e-07 | 6.828 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.575601e-07 | 6.803 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.595256e-07 | 6.797 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.800472e-07 | 6.745 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.759444e-07 | 6.755 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.796780e-07 | 6.746 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.803509e-07 | 6.744 | 1 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.864783e-07 | 6.729 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.014972e-07 | 6.696 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.039658e-07 | 6.690 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.109499e-07 | 6.676 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.405960e-07 | 6.619 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.415925e-07 | 6.617 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.540900e-07 | 6.595 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.587488e-07 | 6.587 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.664639e-07 | 6.574 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.664639e-07 | 6.574 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.707570e-07 | 6.567 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.846614e-07 | 6.546 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.846614e-07 | 6.546 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.157384e-07 | 6.501 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.285024e-07 | 6.483 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.355160e-07 | 6.474 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.402850e-07 | 6.468 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.531934e-07 | 6.452 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.609676e-07 | 6.443 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.919541e-07 | 6.407 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.919541e-07 | 6.407 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.266387e-07 | 6.370 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.061275e-07 | 6.296 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.128231e-07 | 6.290 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.486695e-07 | 6.261 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.888869e-07 | 6.162 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.075239e-07 | 6.150 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.550351e-07 | 6.122 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.819721e-07 | 6.107 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.877066e-07 | 6.052 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.877066e-07 | 6.052 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.877066e-07 | 6.052 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.105787e-07 | 6.041 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.175985e-07 | 6.037 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.032086e-06 | 5.986 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.045682e-06 | 5.981 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.049239e-06 | 5.979 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.093045e-06 | 5.961 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.132647e-06 | 5.946 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.191069e-06 | 5.924 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.197495e-06 | 5.922 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.368119e-06 | 5.864 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.547654e-06 | 5.810 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.547654e-06 | 5.810 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.549854e-06 | 5.810 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.592322e-06 | 5.798 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.811169e-06 | 5.742 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.029801e-06 | 5.693 | 1 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.191176e-06 | 5.659 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.379265e-06 | 5.624 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.379265e-06 | 5.624 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.411477e-06 | 5.618 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.485488e-06 | 5.605 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.507831e-06 | 5.601 | 1 | 1 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.847380e-06 | 5.546 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.875092e-06 | 5.541 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.953963e-06 | 5.530 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.264699e-06 | 5.486 | 1 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.808683e-06 | 5.419 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.799178e-06 | 5.420 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.166709e-06 | 5.380 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.172700e-06 | 5.380 | 1 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.799178e-06 | 5.420 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.166709e-06 | 5.380 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.166709e-06 | 5.380 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.531416e-06 | 5.344 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.833339e-06 | 5.316 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.833339e-06 | 5.316 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.066854e-06 | 5.295 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.159998e-06 | 5.287 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.159998e-06 | 5.287 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.753288e-06 | 5.240 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.753288e-06 | 5.240 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.771503e-06 | 5.239 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.186986e-06 | 5.209 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.335853e-06 | 5.198 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.565862e-06 | 5.183 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.930598e-06 | 5.159 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.265536e-06 | 5.139 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.426591e-06 | 5.129 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.194089e-06 | 5.086 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.424556e-06 | 5.074 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.263131e-06 | 5.083 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.263131e-06 | 5.083 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.874420e-06 | 5.052 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.907759e-06 | 5.050 | 1 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.134806e-06 | 5.039 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.801753e-06 | 5.009 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.115694e-05 | 4.952 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.206898e-05 | 4.918 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.215609e-05 | 4.915 | 1 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.265407e-05 | 4.898 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.336639e-05 | 4.874 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.336639e-05 | 4.874 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.358429e-05 | 4.867 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.371549e-05 | 4.863 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.374877e-05 | 4.862 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.374877e-05 | 4.862 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.374877e-05 | 4.862 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.396332e-05 | 4.855 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.453409e-05 | 4.838 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.545465e-05 | 4.811 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.650124e-05 | 4.782 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.650124e-05 | 4.782 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.650124e-05 | 4.782 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.650124e-05 | 4.782 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.545465e-05 | 4.811 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.545465e-05 | 4.811 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.545465e-05 | 4.811 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.696692e-05 | 4.770 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.767555e-05 | 4.753 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.775996e-05 | 4.751 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.783330e-05 | 4.749 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.783330e-05 | 4.749 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.908051e-05 | 4.719 | 1 | 1 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.991519e-05 | 4.701 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.011107e-05 | 4.697 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.320727e-05 | 4.634 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.393276e-05 | 4.621 | 0 | 0 |
| Translation | R-HSA-72766 | 2.485938e-05 | 4.605 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.638041e-05 | 4.579 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.819669e-05 | 4.550 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.875432e-05 | 4.541 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.930236e-05 | 4.533 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.012269e-05 | 4.521 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.414221e-05 | 4.467 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.480729e-05 | 4.458 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.551311e-05 | 4.450 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.551311e-05 | 4.450 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.551311e-05 | 4.450 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.125411e-05 | 4.385 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.237195e-05 | 4.373 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.632063e-05 | 4.440 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.054192e-05 | 4.392 | 1 | 1 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.125411e-05 | 4.385 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.160054e-05 | 4.381 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.835711e-05 | 4.416 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.054192e-05 | 4.392 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.686321e-05 | 4.433 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.160054e-05 | 4.381 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.290225e-05 | 4.368 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.290225e-05 | 4.368 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.290225e-05 | 4.368 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.408765e-05 | 4.356 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.465051e-05 | 4.350 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.774453e-05 | 4.321 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.774453e-05 | 4.321 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.967252e-05 | 4.304 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.129057e-05 | 4.290 | 1 | 1 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.142936e-05 | 4.289 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.190913e-05 | 4.285 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.190913e-05 | 4.285 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.405708e-05 | 4.267 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.498583e-05 | 4.260 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.571649e-05 | 4.254 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.715459e-05 | 4.243 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.975971e-05 | 4.224 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.147592e-05 | 4.211 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.147592e-05 | 4.211 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.180101e-05 | 4.209 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.323393e-05 | 4.199 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.352217e-05 | 4.197 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.074625e-05 | 4.150 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.317313e-05 | 4.136 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.317313e-05 | 4.136 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.695090e-05 | 4.061 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.695090e-05 | 4.061 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.695090e-05 | 4.061 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.695090e-05 | 4.061 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.695090e-05 | 4.061 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.695090e-05 | 4.061 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.695090e-05 | 4.061 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.695090e-05 | 4.061 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.695090e-05 | 4.061 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.695090e-05 | 4.061 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.695090e-05 | 4.061 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.548636e-05 | 4.068 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.661369e-05 | 4.116 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.833431e-05 | 4.054 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.584822e-05 | 4.066 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.052613e-05 | 4.094 | 1 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.709956e-05 | 4.060 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 9.073609e-05 | 4.042 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.234512e-05 | 4.035 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.234512e-05 | 4.035 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.443300e-05 | 4.025 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.867149e-05 | 4.006 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.037178e-04 | 3.984 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.107562e-04 | 3.956 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.107562e-04 | 3.956 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.109271e-04 | 3.955 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.113429e-04 | 3.953 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.148990e-04 | 3.940 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.189795e-04 | 3.925 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.189795e-04 | 3.925 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.211421e-04 | 3.917 | 1 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.322080e-04 | 3.879 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.322080e-04 | 3.879 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.322080e-04 | 3.879 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.353377e-04 | 3.869 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.367553e-04 | 3.864 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.421029e-04 | 3.847 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.496353e-04 | 3.825 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.578445e-04 | 3.802 | 1 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.617113e-04 | 3.791 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.630659e-04 | 3.788 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.657721e-04 | 3.780 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.657721e-04 | 3.780 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.742327e-04 | 3.759 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.762482e-04 | 3.754 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.762771e-04 | 3.754 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.779924e-04 | 3.750 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.826784e-04 | 3.738 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.858555e-04 | 3.731 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.881373e-04 | 3.726 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.918721e-04 | 3.717 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.988768e-04 | 3.701 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.996466e-04 | 3.700 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.996466e-04 | 3.700 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.007809e-04 | 3.697 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.178721e-04 | 3.662 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.348688e-04 | 3.629 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.348688e-04 | 3.629 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.391522e-04 | 3.621 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.391522e-04 | 3.621 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.391522e-04 | 3.621 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.573300e-04 | 3.590 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.573300e-04 | 3.590 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.618311e-04 | 3.582 | 1 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.801243e-04 | 3.553 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.851214e-04 | 3.545 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.876653e-04 | 3.541 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.876653e-04 | 3.541 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.876653e-04 | 3.541 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.908330e-04 | 3.536 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.973738e-04 | 3.527 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.978248e-04 | 3.526 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.626758e-04 | 3.440 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.989387e-04 | 3.399 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.965077e-04 | 3.402 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.989387e-04 | 3.399 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.672557e-04 | 3.435 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.029864e-04 | 3.395 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.335806e-04 | 3.363 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.386712e-04 | 3.358 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.415617e-04 | 3.355 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.462847e-04 | 3.350 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.531722e-04 | 3.344 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.531722e-04 | 3.344 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.637379e-04 | 3.334 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.687666e-04 | 3.329 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.717944e-04 | 3.326 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.808254e-04 | 3.318 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.822679e-04 | 3.317 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.180842e-04 | 3.286 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.235607e-04 | 3.281 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.305194e-04 | 3.275 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.484457e-04 | 3.261 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.484457e-04 | 3.261 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.621318e-04 | 3.250 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.778540e-04 | 3.238 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.876635e-04 | 3.231 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.880511e-04 | 3.231 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.880511e-04 | 3.231 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.880511e-04 | 3.231 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.162168e-04 | 3.210 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.162168e-04 | 3.210 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.207120e-04 | 3.207 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.207120e-04 | 3.207 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.308028e-04 | 3.200 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.475246e-04 | 3.189 | 1 | 1 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.600773e-04 | 3.180 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.600773e-04 | 3.180 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.106904e-04 | 3.148 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.290454e-04 | 3.137 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.290454e-04 | 3.137 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.393980e-04 | 3.131 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.408053e-04 | 3.130 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.415966e-04 | 3.130 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.044048e-04 | 3.095 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.044048e-04 | 3.095 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.044048e-04 | 3.095 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.044048e-04 | 3.095 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.061352e-04 | 3.094 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.061352e-04 | 3.094 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.112492e-04 | 3.091 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.151890e-04 | 3.089 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.265861e-04 | 3.083 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.356265e-04 | 3.078 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.356265e-04 | 3.078 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.573619e-04 | 3.067 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.573619e-04 | 3.067 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.581696e-04 | 3.066 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.507515e-04 | 3.022 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.507515e-04 | 3.022 | 1 | 1 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.439102e-04 | 3.025 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.439102e-04 | 3.025 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 9.231453e-04 | 3.035 | 1 | 1 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.047909e-03 | 2.980 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.974729e-04 | 3.001 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.166393e-03 | 2.933 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 9.231453e-04 | 3.035 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.066743e-03 | 2.972 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.133534e-03 | 2.946 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.005290e-03 | 2.998 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.875667e-04 | 3.005 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.027006e-03 | 2.988 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.128315e-03 | 2.948 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.743319e-04 | 3.011 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.166393e-03 | 2.933 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.166393e-03 | 2.933 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.875667e-04 | 3.005 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.875667e-04 | 3.005 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.126937e-03 | 2.948 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.488271e-04 | 3.023 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.169507e-03 | 2.932 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.182780e-03 | 2.927 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.186039e-03 | 2.926 | 1 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.277691e-03 | 2.894 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.277691e-03 | 2.894 | 1 | 1 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.324084e-03 | 2.878 | 1 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.335812e-03 | 2.874 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.335812e-03 | 2.874 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.337220e-03 | 2.874 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.360819e-03 | 2.866 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.360819e-03 | 2.866 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.478406e-03 | 2.830 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.568418e-03 | 2.805 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.573127e-03 | 2.803 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.680309e-03 | 2.775 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.680309e-03 | 2.775 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.680309e-03 | 2.775 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.685541e-03 | 2.773 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.723866e-03 | 2.763 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.724073e-03 | 2.763 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.730464e-03 | 2.762 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.780034e-03 | 2.750 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.811222e-03 | 2.742 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.874375e-03 | 2.727 | 1 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.026861e-03 | 2.693 | 1 | 1 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.074927e-03 | 2.683 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.077292e-03 | 2.683 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.081775e-03 | 2.682 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.100718e-03 | 2.678 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.120007e-03 | 2.674 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.160224e-03 | 2.666 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.169622e-03 | 2.664 | 1 | 1 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.274776e-03 | 2.643 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.321250e-03 | 2.634 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.364207e-03 | 2.626 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.373613e-03 | 2.625 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.423324e-03 | 2.616 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.423324e-03 | 2.616 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.423324e-03 | 2.616 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.423324e-03 | 2.616 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.469052e-03 | 2.607 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.472404e-03 | 2.607 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.472404e-03 | 2.607 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.472404e-03 | 2.607 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.508806e-03 | 2.601 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.508806e-03 | 2.601 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.630694e-03 | 2.580 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.640453e-03 | 2.578 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.702547e-03 | 2.568 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.702547e-03 | 2.568 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.722553e-03 | 2.565 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.754673e-03 | 2.560 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.810669e-03 | 2.551 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.830577e-03 | 2.548 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.915212e-03 | 2.535 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.943774e-03 | 2.531 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.000796e-03 | 2.523 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.050612e-03 | 2.516 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.157248e-03 | 2.501 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.157248e-03 | 2.501 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.157248e-03 | 2.501 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.157248e-03 | 2.501 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.219576e-03 | 2.492 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.236369e-03 | 2.490 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.293310e-03 | 2.482 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.409425e-03 | 2.467 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.468116e-03 | 2.460 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.468116e-03 | 2.460 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.468116e-03 | 2.460 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.468116e-03 | 2.460 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.468116e-03 | 2.460 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.656284e-03 | 2.437 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.656284e-03 | 2.437 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.656284e-03 | 2.437 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.744329e-03 | 2.427 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.744329e-03 | 2.427 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.744329e-03 | 2.427 | 1 | 1 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.744329e-03 | 2.427 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.744329e-03 | 2.427 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.744329e-03 | 2.427 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.800969e-03 | 2.420 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.800969e-03 | 2.420 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.800969e-03 | 2.420 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.813989e-03 | 2.419 | 1 | 1 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.909868e-03 | 2.408 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.909868e-03 | 2.408 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.998173e-03 | 2.398 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.998173e-03 | 2.398 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.998173e-03 | 2.398 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.004619e-03 | 2.397 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.067948e-03 | 2.391 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.123127e-03 | 2.385 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.900462e-03 | 2.310 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.537717e-03 | 2.185 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.537717e-03 | 2.185 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.689877e-03 | 2.329 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 4.689877e-03 | 2.329 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 4.689877e-03 | 2.329 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.793704e-03 | 2.237 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.793704e-03 | 2.237 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.423801e-03 | 2.266 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.690429e-03 | 2.329 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.336654e-03 | 2.198 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.537717e-03 | 2.185 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.566858e-03 | 2.340 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.615797e-03 | 2.251 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.537717e-03 | 2.185 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.689877e-03 | 2.329 | 1 | 1 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.689877e-03 | 2.329 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.377651e-03 | 2.269 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.394459e-03 | 2.357 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.423801e-03 | 2.266 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.423801e-03 | 2.266 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.364970e-03 | 2.360 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.377651e-03 | 2.269 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.339724e-03 | 2.198 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.392777e-03 | 2.194 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 5.793704e-03 | 2.237 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.322457e-03 | 2.199 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.360813e-03 | 2.360 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.748143e-03 | 2.240 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.965023e-03 | 2.304 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.537717e-03 | 2.185 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.592025e-03 | 2.181 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.592025e-03 | 2.181 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.592025e-03 | 2.181 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.592025e-03 | 2.181 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.809320e-03 | 2.167 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.809320e-03 | 2.167 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.068817e-03 | 2.151 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.068817e-03 | 2.151 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.068817e-03 | 2.151 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.068817e-03 | 2.151 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.076416e-03 | 2.150 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.090395e-03 | 2.149 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.178544e-03 | 2.144 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.438561e-03 | 2.129 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.765593e-03 | 2.110 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.130202e-03 | 2.090 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 8.420074e-03 | 2.075 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.698423e-03 | 2.061 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.698423e-03 | 2.061 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.698423e-03 | 2.061 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.698423e-03 | 2.061 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.840576e-03 | 2.054 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.086710e-03 | 2.042 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.143555e-03 | 2.039 | 1 | 1 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.692704e-03 | 2.014 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.939136e-03 | 2.003 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.939136e-03 | 2.003 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.005064e-02 | 1.998 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.018291e-02 | 1.992 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.062576e-02 | 1.974 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.062576e-02 | 1.974 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.070151e-02 | 1.971 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.070151e-02 | 1.971 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.114767e-02 | 1.953 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.118825e-02 | 1.951 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.122281e-02 | 1.950 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.131122e-02 | 1.946 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.154588e-02 | 1.938 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.154588e-02 | 1.938 | 1 | 1 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.154588e-02 | 1.938 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.162150e-02 | 1.935 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.162150e-02 | 1.935 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.196670e-02 | 1.922 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.213318e-02 | 1.916 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.221713e-02 | 1.913 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.252058e-02 | 1.902 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.259540e-02 | 1.900 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.259540e-02 | 1.900 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.302755e-02 | 1.885 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.317366e-02 | 1.880 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.317366e-02 | 1.880 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.317366e-02 | 1.880 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.317366e-02 | 1.880 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.317366e-02 | 1.880 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.317366e-02 | 1.880 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.319146e-02 | 1.880 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.393101e-02 | 1.856 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.412678e-02 | 1.850 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.455175e-02 | 1.837 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.487724e-02 | 1.827 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.499444e-02 | 1.824 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.499444e-02 | 1.824 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.550647e-02 | 1.809 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.567377e-02 | 1.805 | 1 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.608032e-02 | 1.794 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.608032e-02 | 1.794 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.643666e-02 | 1.784 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.643666e-02 | 1.784 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.643666e-02 | 1.784 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.643666e-02 | 1.784 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.650472e-02 | 1.782 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.727035e-02 | 1.763 | 1 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.857170e-02 | 1.731 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.864674e-02 | 1.729 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.874186e-02 | 1.727 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.898465e-02 | 1.722 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.898465e-02 | 1.722 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.909938e-02 | 1.719 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 1.909938e-02 | 1.719 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.909938e-02 | 1.719 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.926557e-02 | 1.715 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.926557e-02 | 1.715 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.926557e-02 | 1.715 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.935988e-02 | 1.713 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.935988e-02 | 1.713 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.988173e-02 | 1.702 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.037726e-02 | 1.691 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.056032e-02 | 1.687 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.069041e-02 | 1.684 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.120505e-02 | 1.674 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.141386e-02 | 1.669 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.158687e-02 | 1.666 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.195422e-02 | 1.658 | 1 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.215400e-02 | 1.655 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.302407e-02 | 1.638 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.302407e-02 | 1.638 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.302407e-02 | 1.638 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.391075e-02 | 1.621 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.391075e-02 | 1.621 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.411188e-02 | 1.618 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.462321e-02 | 1.609 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.462321e-02 | 1.609 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.482902e-02 | 1.605 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.516145e-02 | 1.599 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.546732e-02 | 1.594 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.633336e-02 | 1.579 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.659535e-02 | 1.575 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.708226e-02 | 1.567 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.708226e-02 | 1.567 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.744586e-02 | 1.562 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.813849e-02 | 1.551 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.813849e-02 | 1.551 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.813849e-02 | 1.551 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.947252e-02 | 1.531 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.947252e-02 | 1.531 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.947252e-02 | 1.531 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.070085e-02 | 1.513 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.070085e-02 | 1.513 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.070085e-02 | 1.513 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.070085e-02 | 1.513 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.155472e-02 | 1.501 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.175588e-02 | 1.498 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.252270e-02 | 1.488 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.252270e-02 | 1.488 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.252270e-02 | 1.488 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.254669e-02 | 1.487 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.254669e-02 | 1.487 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.311794e-02 | 1.480 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.393118e-02 | 1.469 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.488327e-02 | 1.457 | 1 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.556492e-02 | 1.449 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.575568e-02 | 1.447 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.575568e-02 | 1.447 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.582180e-02 | 1.446 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.612651e-02 | 1.442 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.629335e-02 | 1.440 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.640638e-02 | 1.439 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.640638e-02 | 1.439 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.640638e-02 | 1.439 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.705485e-02 | 1.431 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 5.441741e-02 | 1.264 | 0 | 0 |
| Drug resistance of ALK mutants | R-HSA-9700649 | 5.441741e-02 | 1.264 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 5.441741e-02 | 1.264 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 5.441741e-02 | 1.264 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 5.441741e-02 | 1.264 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 5.441741e-02 | 1.264 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 5.441741e-02 | 1.264 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 5.441741e-02 | 1.264 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 5.441741e-02 | 1.264 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 5.441741e-02 | 1.264 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 5.441741e-02 | 1.264 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 5.441741e-02 | 1.264 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 5.441741e-02 | 1.264 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 5.441741e-02 | 1.264 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 5.441741e-02 | 1.264 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 5.441741e-02 | 1.264 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 5.441741e-02 | 1.264 | 0 | 0 |
| ASP-3026-resistant ALK mutants | R-HSA-9717264 | 5.441741e-02 | 1.264 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 5.441741e-02 | 1.264 | 0 | 0 |
| NVP-TAE684-resistant ALK mutants | R-HSA-9717301 | 5.441741e-02 | 1.264 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 5.441741e-02 | 1.264 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 5.441741e-02 | 1.264 | 0 | 0 |
| alectinib-resistant ALK mutants | R-HSA-9717316 | 5.441741e-02 | 1.264 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 5.441741e-02 | 1.264 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 5.441741e-02 | 1.264 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 5.441741e-02 | 1.264 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 5.441741e-02 | 1.264 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 5.441741e-02 | 1.264 | 0 | 0 |
| brigatinib-resistant ALK mutants | R-HSA-9717319 | 5.441741e-02 | 1.264 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 5.441741e-02 | 1.264 | 0 | 0 |
| crizotinib-resistant ALK mutants | R-HSA-9717326 | 5.441741e-02 | 1.264 | 0 | 0 |
| ceritinib-resistant ALK mutants | R-HSA-9717323 | 5.441741e-02 | 1.264 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 5.441741e-02 | 1.264 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 5.441741e-02 | 1.264 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 5.441741e-02 | 1.264 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.441741e-02 | 1.264 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 5.441741e-02 | 1.264 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 5.441741e-02 | 1.264 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 5.441741e-02 | 1.264 | 0 | 0 |
| lorlatinib-resistant ALK mutants | R-HSA-9717329 | 5.441741e-02 | 1.264 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.516513e-02 | 1.345 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.929644e-02 | 1.227 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.929644e-02 | 1.227 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.929644e-02 | 1.227 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.929644e-02 | 1.227 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.929644e-02 | 1.227 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.749145e-02 | 1.426 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.749145e-02 | 1.426 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.749145e-02 | 1.426 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.315394e-02 | 1.274 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.315394e-02 | 1.274 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.198500e-02 | 1.208 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.198500e-02 | 1.208 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.198500e-02 | 1.208 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 6.198500e-02 | 1.208 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.198500e-02 | 1.208 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 6.198500e-02 | 1.208 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.144896e-02 | 1.146 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.144896e-02 | 1.146 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.167959e-02 | 1.380 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.345076e-02 | 1.272 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.969011e-02 | 1.401 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.683559e-02 | 1.175 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.411937e-02 | 1.130 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.099396e-02 | 1.292 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.116821e-02 | 1.148 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 6.303666e-02 | 1.200 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.590677e-02 | 1.253 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.244803e-02 | 1.280 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.244803e-02 | 1.280 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.291013e-02 | 1.367 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.034391e-02 | 1.153 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.749145e-02 | 1.426 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.167959e-02 | 1.380 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.749145e-02 | 1.426 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.099396e-02 | 1.292 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.291013e-02 | 1.367 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.688517e-02 | 1.329 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 4.275075e-02 | 1.369 | 1 | 1 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.736156e-02 | 1.325 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.688517e-02 | 1.329 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.994381e-02 | 1.222 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.985283e-02 | 1.223 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.325061e-02 | 1.199 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 3.845655e-02 | 1.415 | 1 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.736156e-02 | 1.325 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.683559e-02 | 1.175 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 4.516513e-02 | 1.345 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.516513e-02 | 1.345 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.929644e-02 | 1.227 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.064017e-02 | 1.296 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.523816e-02 | 1.344 | 1 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.625453e-02 | 1.335 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.625453e-02 | 1.335 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.625453e-02 | 1.335 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.523816e-02 | 1.344 | 1 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.034391e-02 | 1.153 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.471755e-02 | 1.127 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.313001e-02 | 1.275 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.144896e-02 | 1.146 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.409434e-02 | 1.356 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.683559e-02 | 1.175 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.930134e-02 | 1.406 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.736156e-02 | 1.325 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.099396e-02 | 1.292 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.159026e-02 | 1.210 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.736156e-02 | 1.325 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.453061e-02 | 1.190 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.494264e-02 | 1.260 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.426286e-02 | 1.354 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.713739e-02 | 1.173 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.236706e-02 | 1.281 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.385141e-02 | 1.358 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.713739e-02 | 1.173 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.969011e-02 | 1.401 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.683559e-02 | 1.175 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 5.994381e-02 | 1.222 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.291013e-02 | 1.367 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.749145e-02 | 1.426 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.367431e-02 | 1.133 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.683559e-02 | 1.175 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.374753e-02 | 1.270 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.957096e-02 | 1.158 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.007317e-02 | 1.221 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.828402e-02 | 1.234 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.475201e-02 | 1.126 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.503389e-02 | 1.125 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.503389e-02 | 1.125 | 1 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.595458e-02 | 1.119 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.643567e-02 | 1.117 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.643567e-02 | 1.117 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.871920e-02 | 1.104 | 1 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.021735e-02 | 1.096 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.151678e-02 | 1.089 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.178692e-02 | 1.087 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 8.178692e-02 | 1.087 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.178692e-02 | 1.087 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.223676e-02 | 1.085 | 1 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.280286e-02 | 1.082 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.280286e-02 | 1.082 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.280286e-02 | 1.082 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.492978e-02 | 1.071 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.492978e-02 | 1.071 | 1 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.574800e-02 | 1.067 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.574800e-02 | 1.067 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.575239e-02 | 1.067 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.575239e-02 | 1.067 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.575239e-02 | 1.067 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.575341e-02 | 1.067 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.820466e-02 | 1.055 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 8.982868e-02 | 1.047 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.982868e-02 | 1.047 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.090211e-02 | 1.041 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.090211e-02 | 1.041 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.090211e-02 | 1.041 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.090211e-02 | 1.041 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.090211e-02 | 1.041 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 9.124657e-02 | 1.040 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 9.124657e-02 | 1.040 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 9.124657e-02 | 1.040 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 9.124657e-02 | 1.040 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 9.124657e-02 | 1.040 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 9.124657e-02 | 1.040 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.157052e-02 | 1.038 | 1 | 1 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 9.215716e-02 | 1.035 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.215716e-02 | 1.035 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.215716e-02 | 1.035 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.348686e-02 | 1.029 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.468452e-02 | 1.024 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.726863e-02 | 1.012 | 1 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.759567e-02 | 1.011 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.033370e-01 | 0.986 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.038262e-01 | 0.984 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.058767e-01 | 0.975 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.058767e-01 | 0.975 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.058767e-01 | 0.975 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.058767e-01 | 0.975 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.058767e-01 | 0.975 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.058767e-01 | 0.975 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.058767e-01 | 0.975 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.058767e-01 | 0.975 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.069905e-01 | 0.971 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.069905e-01 | 0.971 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.069905e-01 | 0.971 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 1.069905e-01 | 0.971 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.087176e-01 | 0.964 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.087176e-01 | 0.964 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.087176e-01 | 0.964 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.095501e-01 | 0.960 | 1 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.102589e-01 | 0.958 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 1.102589e-01 | 0.958 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.102589e-01 | 0.958 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.109398e-01 | 0.955 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.109398e-01 | 0.955 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.110426e-01 | 0.955 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.139124e-01 | 0.943 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.150220e-01 | 0.939 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 1.150220e-01 | 0.939 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 1.150220e-01 | 0.939 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.150220e-01 | 0.939 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.160858e-01 | 0.935 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 1.160858e-01 | 0.935 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.160858e-01 | 0.935 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.182418e-01 | 0.927 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.186138e-01 | 0.926 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.186138e-01 | 0.926 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 1.186138e-01 | 0.926 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.193675e-01 | 0.923 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.196260e-01 | 0.922 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.233662e-01 | 0.909 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.237167e-01 | 0.908 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.249591e-01 | 0.903 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.269793e-01 | 0.896 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.269793e-01 | 0.896 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.269793e-01 | 0.896 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.269793e-01 | 0.896 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.269793e-01 | 0.896 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.269793e-01 | 0.896 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 1.269793e-01 | 0.896 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.269793e-01 | 0.896 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.269793e-01 | 0.896 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.269793e-01 | 0.896 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.271767e-01 | 0.896 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 1.271767e-01 | 0.896 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.276868e-01 | 0.894 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.307336e-01 | 0.884 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.322619e-01 | 0.879 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.352365e-01 | 0.869 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.352365e-01 | 0.869 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.366104e-01 | 0.865 | 1 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.377551e-01 | 0.861 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.394389e-01 | 0.856 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.397655e-01 | 0.855 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 1.397655e-01 | 0.855 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.409570e-01 | 0.851 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.430626e-01 | 0.844 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.452624e-01 | 0.838 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.458943e-01 | 0.836 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.458943e-01 | 0.836 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.458943e-01 | 0.836 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.458943e-01 | 0.836 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 1.458943e-01 | 0.836 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.458943e-01 | 0.836 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.458943e-01 | 0.836 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.458943e-01 | 0.836 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.458943e-01 | 0.836 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.458943e-01 | 0.836 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.527523e-01 | 0.816 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.527523e-01 | 0.816 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.528815e-01 | 0.816 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.528815e-01 | 0.816 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.528815e-01 | 0.816 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.528815e-01 | 0.816 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 1.545384e-01 | 0.811 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 1.545384e-01 | 0.811 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 1.545384e-01 | 0.811 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.545384e-01 | 0.811 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 1.545384e-01 | 0.811 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.545384e-01 | 0.811 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.545384e-01 | 0.811 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.545384e-01 | 0.811 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 1.545384e-01 | 0.811 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.545384e-01 | 0.811 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 1.545384e-01 | 0.811 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.545384e-01 | 0.811 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.545384e-01 | 0.811 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.545384e-01 | 0.811 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.555679e-01 | 0.808 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.606126e-01 | 0.794 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.624866e-01 | 0.789 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.653375e-01 | 0.782 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.661369e-01 | 0.780 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.661369e-01 | 0.780 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.675863e-01 | 0.776 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.677439e-01 | 0.775 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.684598e-01 | 0.774 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.694820e-01 | 0.771 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 1.723806e-01 | 0.764 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.743466e-01 | 0.759 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.745814e-01 | 0.758 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.769532e-01 | 0.752 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.769532e-01 | 0.752 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.769532e-01 | 0.752 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.769532e-01 | 0.752 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.769532e-01 | 0.752 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.786852e-01 | 0.748 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.797767e-01 | 0.745 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.851956e-01 | 0.732 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.851956e-01 | 0.732 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.851956e-01 | 0.732 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.851956e-01 | 0.732 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.851956e-01 | 0.732 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 1.873646e-01 | 0.727 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.879999e-01 | 0.726 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.879999e-01 | 0.726 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.880710e-01 | 0.726 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.880710e-01 | 0.726 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.937434e-01 | 0.713 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.937434e-01 | 0.713 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.949303e-01 | 0.710 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 1.992604e-01 | 0.701 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.992604e-01 | 0.701 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.005546e-01 | 0.698 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 2.005546e-01 | 0.698 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 2.005546e-01 | 0.698 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 2.005546e-01 | 0.698 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 2.005546e-01 | 0.698 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 2.005546e-01 | 0.698 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.005546e-01 | 0.698 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 2.005546e-01 | 0.698 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 2.005546e-01 | 0.698 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 2.005546e-01 | 0.698 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 2.005546e-01 | 0.698 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 2.005546e-01 | 0.698 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.016224e-01 | 0.695 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 2.026151e-01 | 0.693 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.053660e-01 | 0.687 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.053660e-01 | 0.687 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.053660e-01 | 0.687 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.053660e-01 | 0.687 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.079671e-01 | 0.682 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 2.079671e-01 | 0.682 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.102512e-01 | 0.677 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.107177e-01 | 0.676 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.107177e-01 | 0.676 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.172254e-01 | 0.663 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.224140e-01 | 0.653 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.224140e-01 | 0.653 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.224140e-01 | 0.653 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.257562e-01 | 0.646 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.257562e-01 | 0.646 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.257562e-01 | 0.646 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.257562e-01 | 0.646 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.257562e-01 | 0.646 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.341553e-01 | 0.630 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.370516e-01 | 0.625 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 2.440688e-01 | 0.612 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 2.440688e-01 | 0.612 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 2.440688e-01 | 0.612 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 2.440688e-01 | 0.612 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 2.440688e-01 | 0.612 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.459663e-01 | 0.609 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 2.461021e-01 | 0.609 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.462824e-01 | 0.609 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.462824e-01 | 0.609 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.462824e-01 | 0.609 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.462824e-01 | 0.609 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.462824e-01 | 0.609 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.476628e-01 | 0.606 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.518482e-01 | 0.599 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.518482e-01 | 0.599 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.518482e-01 | 0.599 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.544580e-01 | 0.594 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.581787e-01 | 0.588 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.581787e-01 | 0.588 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.667735e-01 | 0.574 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.667735e-01 | 0.574 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.668697e-01 | 0.574 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 2.793093e-01 | 0.554 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.817980e-01 | 0.550 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.817980e-01 | 0.550 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.817980e-01 | 0.550 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.817980e-01 | 0.550 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 2.852171e-01 | 0.545 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.852171e-01 | 0.545 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.852171e-01 | 0.545 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.852171e-01 | 0.545 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.852171e-01 | 0.545 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.852171e-01 | 0.545 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.852171e-01 | 0.545 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 2.852171e-01 | 0.545 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.852171e-01 | 0.545 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.852171e-01 | 0.545 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.852171e-01 | 0.545 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.852171e-01 | 0.545 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.874508e-01 | 0.541 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.874508e-01 | 0.541 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.874508e-01 | 0.541 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.874508e-01 | 0.541 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.874508e-01 | 0.541 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.897626e-01 | 0.538 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.968938e-01 | 0.527 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.968938e-01 | 0.527 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.968938e-01 | 0.527 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.968938e-01 | 0.527 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.074618e-01 | 0.512 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.079652e-01 | 0.511 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.079652e-01 | 0.511 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 3.079652e-01 | 0.511 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.079652e-01 | 0.511 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 3.112789e-01 | 0.507 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.120048e-01 | 0.506 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.120342e-01 | 0.506 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.120342e-01 | 0.506 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.144288e-01 | 0.502 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.173954e-01 | 0.498 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.221188e-01 | 0.492 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 3.221188e-01 | 0.492 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.241278e-01 | 0.489 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.241278e-01 | 0.489 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.241278e-01 | 0.489 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.241278e-01 | 0.489 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 3.241278e-01 | 0.489 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.241278e-01 | 0.489 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 3.241278e-01 | 0.489 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 3.241278e-01 | 0.489 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.241278e-01 | 0.489 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.241278e-01 | 0.489 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.241278e-01 | 0.489 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.241278e-01 | 0.489 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 3.241278e-01 | 0.489 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 3.241278e-01 | 0.489 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.248385e-01 | 0.488 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.271937e-01 | 0.485 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.271937e-01 | 0.485 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.271937e-01 | 0.485 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.283596e-01 | 0.484 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.283596e-01 | 0.484 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.283596e-01 | 0.484 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 3.283596e-01 | 0.484 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.292025e-01 | 0.483 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.324732e-01 | 0.478 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 3.330004e-01 | 0.478 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.423483e-01 | 0.466 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.423483e-01 | 0.466 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.439140e-01 | 0.464 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.450200e-01 | 0.462 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.450200e-01 | 0.462 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 3.466219e-01 | 0.460 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 3.466219e-01 | 0.460 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.485861e-01 | 0.458 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.509847e-01 | 0.455 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.546483e-01 | 0.450 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.548505e-01 | 0.450 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.574751e-01 | 0.447 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 3.575758e-01 | 0.447 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 3.609226e-01 | 0.443 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.609226e-01 | 0.443 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.609226e-01 | 0.443 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.609226e-01 | 0.443 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.609226e-01 | 0.443 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.609226e-01 | 0.443 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.609226e-01 | 0.443 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.609226e-01 | 0.443 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.609226e-01 | 0.443 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.609226e-01 | 0.443 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.609226e-01 | 0.443 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 3.609226e-01 | 0.443 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.609226e-01 | 0.443 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.609226e-01 | 0.443 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.609226e-01 | 0.443 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.609226e-01 | 0.443 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.609226e-01 | 0.443 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.609226e-01 | 0.443 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.609226e-01 | 0.443 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.686026e-01 | 0.433 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.686026e-01 | 0.433 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.686026e-01 | 0.433 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.686026e-01 | 0.433 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.686026e-01 | 0.433 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.725526e-01 | 0.429 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.725526e-01 | 0.429 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.725526e-01 | 0.429 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.725526e-01 | 0.429 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 3.746906e-01 | 0.426 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.875608e-01 | 0.412 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.875608e-01 | 0.412 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.875608e-01 | 0.412 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.883723e-01 | 0.411 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.883723e-01 | 0.411 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.883723e-01 | 0.411 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.883723e-01 | 0.411 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.883723e-01 | 0.411 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.883723e-01 | 0.411 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.898799e-01 | 0.409 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.898799e-01 | 0.409 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 3.957163e-01 | 0.403 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.957163e-01 | 0.403 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 3.957163e-01 | 0.403 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 3.957163e-01 | 0.403 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 3.957163e-01 | 0.403 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.957163e-01 | 0.403 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.957163e-01 | 0.403 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 4.024807e-01 | 0.395 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.078626e-01 | 0.389 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.078626e-01 | 0.389 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.078626e-01 | 0.389 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.078626e-01 | 0.389 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.078626e-01 | 0.389 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 4.078626e-01 | 0.389 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.172947e-01 | 0.380 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.172947e-01 | 0.380 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.198127e-01 | 0.377 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.200458e-01 | 0.377 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.270454e-01 | 0.370 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.270454e-01 | 0.370 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.270454e-01 | 0.370 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.270454e-01 | 0.370 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.270454e-01 | 0.370 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 4.286178e-01 | 0.368 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 4.286178e-01 | 0.368 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.286178e-01 | 0.368 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.286178e-01 | 0.368 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.286178e-01 | 0.368 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.286178e-01 | 0.368 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.286178e-01 | 0.368 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 4.286178e-01 | 0.368 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.286178e-01 | 0.368 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.286178e-01 | 0.368 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.286178e-01 | 0.368 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.286178e-01 | 0.368 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.286178e-01 | 0.368 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 4.319864e-01 | 0.365 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.319864e-01 | 0.365 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.458964e-01 | 0.351 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.458964e-01 | 0.351 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.458964e-01 | 0.351 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.458964e-01 | 0.351 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.458964e-01 | 0.351 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.458964e-01 | 0.351 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.465407e-01 | 0.350 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 4.528895e-01 | 0.344 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.580573e-01 | 0.339 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 4.597297e-01 | 0.337 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 4.597297e-01 | 0.337 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 4.597297e-01 | 0.337 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.597297e-01 | 0.337 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.597297e-01 | 0.337 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.597297e-01 | 0.337 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.597297e-01 | 0.337 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.597297e-01 | 0.337 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.597297e-01 | 0.337 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.597297e-01 | 0.337 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.597297e-01 | 0.337 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.597297e-01 | 0.337 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.597297e-01 | 0.337 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.597297e-01 | 0.337 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.609436e-01 | 0.336 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 4.635957e-01 | 0.334 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.643950e-01 | 0.333 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.643950e-01 | 0.333 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.643950e-01 | 0.333 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.643950e-01 | 0.333 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.643950e-01 | 0.333 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.643950e-01 | 0.333 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.689724e-01 | 0.329 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.751822e-01 | 0.323 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.751822e-01 | 0.323 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.800722e-01 | 0.319 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.825237e-01 | 0.316 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.825237e-01 | 0.316 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.891493e-01 | 0.311 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.891493e-01 | 0.311 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.891493e-01 | 0.311 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.891493e-01 | 0.311 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.891493e-01 | 0.311 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.891493e-01 | 0.311 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.891493e-01 | 0.311 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.891493e-01 | 0.311 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.892446e-01 | 0.310 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.892446e-01 | 0.310 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.892446e-01 | 0.310 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.892446e-01 | 0.310 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.892446e-01 | 0.310 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.892446e-01 | 0.310 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.892446e-01 | 0.310 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.928715e-01 | 0.307 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.002678e-01 | 0.301 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.002678e-01 | 0.301 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 5.002678e-01 | 0.301 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.002678e-01 | 0.301 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.002678e-01 | 0.301 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 5.031203e-01 | 0.298 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.031203e-01 | 0.298 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.031203e-01 | 0.298 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 5.159649e-01 | 0.287 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.169687e-01 | 0.287 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.169687e-01 | 0.287 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.169687e-01 | 0.287 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.169687e-01 | 0.287 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.169687e-01 | 0.287 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.169687e-01 | 0.287 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.169687e-01 | 0.287 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 5.169687e-01 | 0.287 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.169687e-01 | 0.287 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 5.169687e-01 | 0.287 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.169687e-01 | 0.287 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.169687e-01 | 0.287 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.169687e-01 | 0.287 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.176156e-01 | 0.286 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 5.176156e-01 | 0.286 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.176156e-01 | 0.286 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.176156e-01 | 0.286 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 5.278359e-01 | 0.278 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.302735e-01 | 0.276 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.345576e-01 | 0.272 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.345576e-01 | 0.272 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.415686e-01 | 0.266 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 5.432746e-01 | 0.265 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.432746e-01 | 0.265 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 5.432746e-01 | 0.265 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.432746e-01 | 0.265 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.432746e-01 | 0.265 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.432746e-01 | 0.265 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.432746e-01 | 0.265 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.510866e-01 | 0.259 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.510866e-01 | 0.259 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.510866e-01 | 0.259 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 5.564257e-01 | 0.255 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.671972e-01 | 0.246 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.671972e-01 | 0.246 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.671972e-01 | 0.246 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.671972e-01 | 0.246 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.671972e-01 | 0.246 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 5.681495e-01 | 0.246 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.681495e-01 | 0.246 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 5.681495e-01 | 0.246 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.681495e-01 | 0.246 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.681495e-01 | 0.246 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.681495e-01 | 0.246 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 5.681495e-01 | 0.246 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 5.681495e-01 | 0.246 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.681495e-01 | 0.246 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.681495e-01 | 0.246 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.681495e-01 | 0.246 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.681495e-01 | 0.246 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 5.693906e-01 | 0.245 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.706461e-01 | 0.244 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.725378e-01 | 0.242 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 5.753279e-01 | 0.240 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.819744e-01 | 0.235 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.828861e-01 | 0.234 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.828861e-01 | 0.234 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.828861e-01 | 0.234 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.828861e-01 | 0.234 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.916710e-01 | 0.228 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.916710e-01 | 0.228 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.916710e-01 | 0.228 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.916710e-01 | 0.228 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.916710e-01 | 0.228 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.916710e-01 | 0.228 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 5.916710e-01 | 0.228 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.916710e-01 | 0.228 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.916710e-01 | 0.228 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.916710e-01 | 0.228 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.916710e-01 | 0.228 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.916710e-01 | 0.228 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.916710e-01 | 0.228 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.916710e-01 | 0.228 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.916710e-01 | 0.228 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.981514e-01 | 0.223 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.981514e-01 | 0.223 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.981514e-01 | 0.223 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.981514e-01 | 0.223 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.981514e-01 | 0.223 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.989484e-01 | 0.223 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.064308e-01 | 0.217 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.129926e-01 | 0.213 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 6.139127e-01 | 0.212 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.139127e-01 | 0.212 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.139127e-01 | 0.212 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.139127e-01 | 0.212 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.139127e-01 | 0.212 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.139127e-01 | 0.212 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.139127e-01 | 0.212 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.139127e-01 | 0.212 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.147621e-01 | 0.211 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.349441e-01 | 0.197 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.349441e-01 | 0.197 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.349441e-01 | 0.197 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.349441e-01 | 0.197 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 6.349441e-01 | 0.197 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 6.349441e-01 | 0.197 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 6.349441e-01 | 0.197 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 6.349441e-01 | 0.197 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 6.349441e-01 | 0.197 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.349441e-01 | 0.197 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.349441e-01 | 0.197 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.349441e-01 | 0.197 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 6.414078e-01 | 0.193 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 6.523986e-01 | 0.185 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.548311e-01 | 0.184 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.548311e-01 | 0.184 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.548311e-01 | 0.184 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 6.548311e-01 | 0.184 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.548311e-01 | 0.184 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.622092e-01 | 0.179 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.632930e-01 | 0.178 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 6.632930e-01 | 0.178 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.637419e-01 | 0.178 | 1 | 1 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 6.637419e-01 | 0.178 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 6.681518e-01 | 0.175 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.736359e-01 | 0.172 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.736359e-01 | 0.172 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.736359e-01 | 0.172 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.736359e-01 | 0.172 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.736359e-01 | 0.172 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.736359e-01 | 0.172 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.736359e-01 | 0.172 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.736359e-01 | 0.172 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.736359e-01 | 0.172 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.736359e-01 | 0.172 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.736359e-01 | 0.172 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.736359e-01 | 0.172 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.736359e-01 | 0.172 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.809076e-01 | 0.167 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.908281e-01 | 0.161 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.914173e-01 | 0.160 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.914173e-01 | 0.160 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.914173e-01 | 0.160 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.914173e-01 | 0.160 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.914173e-01 | 0.160 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.914173e-01 | 0.160 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.914173e-01 | 0.160 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.914173e-01 | 0.160 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.932598e-01 | 0.159 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.932598e-01 | 0.159 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.932598e-01 | 0.159 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.932598e-01 | 0.159 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.932598e-01 | 0.159 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.052143e-01 | 0.152 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.052143e-01 | 0.152 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.082309e-01 | 0.150 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.082309e-01 | 0.150 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.082309e-01 | 0.150 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.082309e-01 | 0.150 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.082309e-01 | 0.150 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.082309e-01 | 0.150 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 7.082309e-01 | 0.150 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.082309e-01 | 0.150 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.082309e-01 | 0.150 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.136498e-01 | 0.147 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.140762e-01 | 0.146 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.166795e-01 | 0.145 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.167778e-01 | 0.145 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.167778e-01 | 0.145 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 7.233369e-01 | 0.141 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.233369e-01 | 0.141 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.233369e-01 | 0.141 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.233369e-01 | 0.141 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.241293e-01 | 0.140 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.241293e-01 | 0.140 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.241293e-01 | 0.140 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.241293e-01 | 0.140 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.261951e-01 | 0.139 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.273131e-01 | 0.138 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.279575e-01 | 0.138 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.279575e-01 | 0.138 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.288732e-01 | 0.137 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.324860e-01 | 0.135 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.328970e-01 | 0.135 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.387609e-01 | 0.131 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.391623e-01 | 0.131 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.391623e-01 | 0.131 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.391623e-01 | 0.131 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 7.391623e-01 | 0.131 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.391623e-01 | 0.131 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.391623e-01 | 0.131 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.491956e-01 | 0.125 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.500667e-01 | 0.125 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.533771e-01 | 0.123 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.533771e-01 | 0.123 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.533771e-01 | 0.123 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.533771e-01 | 0.123 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.533771e-01 | 0.123 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.533771e-01 | 0.123 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 7.533771e-01 | 0.123 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.533771e-01 | 0.123 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.585035e-01 | 0.120 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.592699e-01 | 0.120 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.592699e-01 | 0.120 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.592699e-01 | 0.120 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.592699e-01 | 0.120 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.592699e-01 | 0.120 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.592699e-01 | 0.120 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.655239e-01 | 0.116 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.668179e-01 | 0.115 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.668179e-01 | 0.115 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 7.668179e-01 | 0.115 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.668179e-01 | 0.115 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.668179e-01 | 0.115 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.689919e-01 | 0.114 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.773423e-01 | 0.109 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 7.773423e-01 | 0.109 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.783702e-01 | 0.109 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.874132e-01 | 0.104 | 0 | 0 |
| Methylation | R-HSA-156581 | 7.874132e-01 | 0.104 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.915442e-01 | 0.102 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.915442e-01 | 0.102 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.915442e-01 | 0.102 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.961298e-01 | 0.099 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.029070e-01 | 0.095 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.029070e-01 | 0.095 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.029070e-01 | 0.095 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.029070e-01 | 0.095 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.029070e-01 | 0.095 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.029070e-01 | 0.095 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.045286e-01 | 0.094 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.045286e-01 | 0.094 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.112661e-01 | 0.091 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.126182e-01 | 0.090 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.136511e-01 | 0.090 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.136511e-01 | 0.090 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 8.138025e-01 | 0.089 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 8.179479e-01 | 0.087 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.204075e-01 | 0.086 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.238102e-01 | 0.084 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.238102e-01 | 0.084 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.238102e-01 | 0.084 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.238102e-01 | 0.084 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.244276e-01 | 0.084 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.244276e-01 | 0.084 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.283992e-01 | 0.082 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.327930e-01 | 0.079 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.334159e-01 | 0.079 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.334159e-01 | 0.079 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.334159e-01 | 0.079 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.424986e-01 | 0.074 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.424986e-01 | 0.074 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.424986e-01 | 0.074 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.510865e-01 | 0.070 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.510865e-01 | 0.070 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.510865e-01 | 0.070 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.510865e-01 | 0.070 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.551505e-01 | 0.068 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.592066e-01 | 0.066 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 8.592066e-01 | 0.066 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.592066e-01 | 0.066 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.592929e-01 | 0.066 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.592929e-01 | 0.066 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.621395e-01 | 0.064 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.650695e-01 | 0.063 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.668845e-01 | 0.062 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 8.741441e-01 | 0.058 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 8.810082e-01 | 0.055 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.810082e-01 | 0.055 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.874983e-01 | 0.052 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.874983e-01 | 0.052 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.874983e-01 | 0.052 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.874983e-01 | 0.052 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.874983e-01 | 0.052 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.886904e-01 | 0.051 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.918614e-01 | 0.050 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.935260e-01 | 0.049 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 8.935260e-01 | 0.049 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.936348e-01 | 0.049 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.936348e-01 | 0.049 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.936348e-01 | 0.049 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.936348e-01 | 0.049 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.958640e-01 | 0.048 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.994369e-01 | 0.046 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.994369e-01 | 0.046 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.994369e-01 | 0.046 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 8.994369e-01 | 0.046 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.994369e-01 | 0.046 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.026164e-01 | 0.044 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.049229e-01 | 0.043 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.049229e-01 | 0.043 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.049229e-01 | 0.043 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.049229e-01 | 0.043 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.068850e-01 | 0.042 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.101099e-01 | 0.041 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.135309e-01 | 0.039 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.146776e-01 | 0.039 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.150142e-01 | 0.039 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.196512e-01 | 0.036 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.206413e-01 | 0.036 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 9.240355e-01 | 0.034 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.257212e-01 | 0.034 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.281808e-01 | 0.032 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.281808e-01 | 0.032 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.281808e-01 | 0.032 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.321002e-01 | 0.031 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.321002e-01 | 0.031 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.352330e-01 | 0.029 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.352330e-01 | 0.029 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.358058e-01 | 0.029 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.361369e-01 | 0.029 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.411206e-01 | 0.026 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.435827e-01 | 0.025 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.457541e-01 | 0.024 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.487153e-01 | 0.023 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.487153e-01 | 0.023 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.509019e-01 | 0.022 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.515151e-01 | 0.022 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.515151e-01 | 0.022 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.526937e-01 | 0.021 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.531334e-01 | 0.021 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.541621e-01 | 0.020 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.552679e-01 | 0.020 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.566648e-01 | 0.019 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.566648e-01 | 0.019 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.612681e-01 | 0.017 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.629112e-01 | 0.016 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.648072e-01 | 0.016 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.690452e-01 | 0.014 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.690610e-01 | 0.014 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.692918e-01 | 0.014 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.707510e-01 | 0.013 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.723487e-01 | 0.012 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.744326e-01 | 0.011 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.766375e-01 | 0.010 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.773041e-01 | 0.010 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.779140e-01 | 0.010 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.791209e-01 | 0.009 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.791209e-01 | 0.009 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.792085e-01 | 0.009 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.802618e-01 | 0.009 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.811193e-01 | 0.008 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.811612e-01 | 0.008 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.823602e-01 | 0.008 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.827013e-01 | 0.008 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.827013e-01 | 0.008 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.842358e-01 | 0.007 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.844139e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.850975e-01 | 0.007 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.850975e-01 | 0.007 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.850975e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.850975e-01 | 0.007 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.855532e-01 | 0.006 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.859121e-01 | 0.006 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.872866e-01 | 0.006 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.874104e-01 | 0.006 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.876799e-01 | 0.005 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.882882e-01 | 0.005 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.887242e-01 | 0.005 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.893647e-01 | 0.005 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.919304e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.919718e-01 | 0.004 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.924109e-01 | 0.003 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.942719e-01 | 0.002 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.968929e-01 | 0.001 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.972447e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.975382e-01 | 0.001 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.976009e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.977187e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.978005e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.979210e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.983150e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.983982e-01 | 0.001 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.987891e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.988815e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.989428e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.990008e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.990015e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.992537e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.992739e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.994224e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.995324e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998777e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999331e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999368e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999439e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999728e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999787e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999885e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999886e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999959e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999963e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999963e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999998e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |